US8594777B2 - System and method for reconstructing cardiac activation information - Google Patents

System and method for reconstructing cardiac activation information Download PDF

Info

Publication number
US8594777B2
US8594777B2 US13438534 US201213438534A US8594777B2 US 8594777 B2 US8594777 B2 US 8594777B2 US 13438534 US13438534 US 13438534 US 201213438534 A US201213438534 A US 201213438534A US 8594777 B2 US8594777 B2 US 8594777B2
Authority
US
Grant status
Grant
Patent type
Prior art keywords
signal
biological
activation
time
signals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US13438534
Other versions
US20120283579A1 (en )
Inventor
Carey Robert Briggs
Sanjiv Narayan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Topera Inc
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02405Determining heart rate variability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/0255Recording instruments specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/04011Vector-cardiography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/04012Analysis of electro-cardiograms, electro-encephalograms, electro-myograms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/0402Electrocardiography, i.e. ECG
    • A61B5/0408Electrodes specially adapted therefor
    • A61B5/042Electrodes specially adapted therefor for introducing into the body
    • A61B5/0422Multiple electrode holders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/0402Electrocardiography, i.e. ECG
    • A61B5/0452Detecting specific parameters of the electrocardiograph cycle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/0402Electrocardiography, i.e. ECG
    • A61B5/0452Detecting specific parameters of the electrocardiograph cycle
    • A61B5/046Detecting fibrillation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/0402Electrocardiography, i.e. ECG
    • A61B5/0452Detecting specific parameters of the electrocardiograph cycle
    • A61B5/0464Detecting tachycardy or brachycardy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A61B5/7217Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7239Details of waveform analysis using differentiation including higher order derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7246Details of waveform analysis using correlation, e.g. template matching or determination of similarity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7278Artificial waveform generation or derivation, e.g. synthesising signals from measured signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7282Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/742Details of notification to user or communication with user or patient ; user input means using visual displays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/742Details of notification to user or communication with user or patient ; user input means using visual displays
    • A61B5/743Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04Arrangements of multiple sensors of the same type
    • A61B2562/046Arrangements of multiple sensors of the same type in a matrix array

Abstract

An example system and method of reconstructing biological activation information are disclosed. A first biological signal and a second biological signal associated with an organ are processed via a computing device to determine whether there is a point of change in a derivative of the first biological signal with respect to a derivative of the second biological signal above a threshold. An activation onset time is assigned in the first biological signal at the point of change to define biological activation associated with the organ in the first biological signal if it is determined that the point of change is above the threshold.

Description

CROSS REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 13/217,123 filed on Aug. 24, 2011, now U.S. Pat. No. 8,165,666, which claims priority to and benefit of U.S. Provisional Patent Application No. 61/481,607 filed on May 2, 2011, both of which are incorporated herein by reference in their entireties.

FEDERAL GRANT

This invention was made with government support under Grants R01 HL83359, HL83359-S1 and HL103800 awarded by the National Institutes of Health. The government has certain rights in the invention.

BACKGROUND

1. Field

The present application relates generally to heart rhythm disorders. More specifically, the present application is directed to a system and method for reconstructing cardiac activation information (activation onset) associated with heart rhythm disorders.

2. Brief Discussion of Related Art

Heart (cardiac) rhythm disorders are common and represent significant causes of morbidity and death throughout the world. Malfunction of the electrical system in the heart represents a proximate cause of heart rhythm disorders. Heart rhythm disorders exist in many forms, of which the most complex and difficult to treat are atrial fibrillation (AF), ventricular tachycardia (VT) and ventricular fibrillation (VF). Other rhythm disorders are more simple to treat, but may also be clinically significant including atrial tachycardia (AT), supraventricular tachycardia (SVT), atrial flutter (AFL), supraventricular ectopic complexes/beats (SVE) and premature ventricular complexes/beats (PVC). While under normal conditions the sinus node keeps the heart in sinus rhythm, under certain conditions rapid activation of the normal sinus node can cause inappropriate sinus tachycardia or sinus node reentry, both of which also represent heart rhythm disorders.

Treatment of heart rhythm disorders—particularly complex rhythm disorders of AF, VF and polymorphic VT—can be very difficult. Pharmacologic therapy for complex rhythm disorder is not optimal, with poor efficacy and significant side effects. Ablation has been used increasingly in connection with heart rhythm disorders by maneuvering a sensor/probe to the heart through the blood vessels, or directly at surgery, and delivering energy to a location of the heart that harbors a cause of the heart rhythm disorder to mitigate and in some cases to eliminate the heart rhythm disorder. However, in complex rhythm disorders ablation is often difficult and ineffectual because tools that identify and locate a cause of the heart rhythm disorder are poor and hinder attempts to deliver energy to the correct region of the heart to eliminate the disorder.

Certain systems and methods are known for treating simple heart rhythm disorders. In a simple heart rhythm disorder (e.g., atrial tachycardia), consistent activation onset patterns from beat to beat can generally be traced back to an earliest location, which can be ablated to mitigate and in some cases to eliminate the disorder. Even in simple heart rhythm disorders, such ablation of the cause of a heart rhythm disorder is challenging and experienced practitioners often require hours to ablate simple rhythm disorders with consistent beat-to-beat activation patterns, such as atrial tachycardia.

There are no known systems and methods that have been successful with respect to identifying causes for the complex rhythm disorders such as AF, VF or polymorphic VT. In a complex rhythm disorder, an earliest location of activation onsets cannot be identified because activation onset patterns change from beat to beat, and are “continuous” such that there is no identifiable earliest point (or start) or latest point (or end).

Diagnosing and treating heart rhythm disorders often involves the introduction of a catheter having a plurality of sensors/probes into the heart through the blood vessels of a patient. The sensors detect electric activity of the heart at sensor locations in the heart. The electric activity is generally processed into electrogram signals that represent the activation of the heart at the sensor locations.

In a simple heart rhythm disorder, the signal at each sensor location is generally consistent from beat to beat in timing and often in shape and number of its deflections, enabling identification of activation onsets at each sensor location. However, in a complex rhythm disorder, the signal at each sensor location from beat to beat may transition between one, several, and multiple deflections of various shapes. For instance, when a signal for a sensor location in AF includes 5, 7, 11 or more deflections, it is difficult if not impossible to identify which deflections in the signal are at or near the sensor location in the heart (i.e., local activation) versus a further removed location still sensed by the sensor in the heart (i.e., far-field activation) or simply noise from another part of the patient's heart, other anatomic structures, movement or motion of the sensor relative to the heart or external electronic systems.

There are no known systems and methods that have been able to reconstruct cardiac activation information (onsets) in variously shaped signals associated with heart rhythm disorders, especially in complex rhythm disorders, to facilitate identification of a cause of the heart rhythm disorders and their elimination.

SUMMARY

The present invention is applicable to reconstructing activation information of various rhythm disorders, including heart rhythm disorders, as well as other biological rhythm disorders, such as neurological seizures, esophageal spasms, bladder instability, irritable bowel syndrome, and other biological disorders for which biological activation information can be reconstructed to permit determination, diagnosis, and/or treatment of the cause or source of the disorders. It is particularly useful, however, in complex rhythm disorders which result in complex activation patterns, and especially useful in complex rhythm disorders of the heart, in order to find the cause(s) or source(s) of the disorders such that they can be treated with expediency.

Complex heart rhythm disorders typically result in activation patterns that are extremely difficult to decipher and the ability to determine accurate activation information of heart beats in complex disorders has previously not been possible. Among the advantages of the present invention is the ability to reconstruct cardiac activation information such that a determination of the cause and/or source of the disorder can be determined and treated. Another advantage is that the present invention provides a system and method which can be carried out rapidly while a sensing device—such as a catheter having sensors thereon—is used in or near the patient and can be followed by treatment of cardiac tissue to ameliorate the disorder and in many cases cure the disorder. Treatment may thus occur immediately upon computing the reconstructed cardiac information, since it will provide the location(s) of the cause or source of the disorder.

Prior systems and methods suffered from the inability to determine the source of heart rhythm disorders and consequently provided no means of targeting the source for meaningful and curative treatment. Additionally, prior systems and methods required numerous and complex steps of treatment and yet still failed to provide a means of reconstructing cardiac activation information sufficient to identify the cause(s) or source(s) of the heart rhythm disorder.

In contrast to prior systems and methods, the present invention provides a relatively few number of steps to reconstruct the activation information in order to determine the activation onset times at various sensor locations for a heart beat amidst the virtually indiscernible activation patterns.

As used herein, reconstruction is a process of identifying activation onset time in a cardiac or biological signal at a sensor location distinct from nearby or adjacent sensor locations for one or more beats of a biological or cardiac rhythm disorder.

As used herein, activation onset time is a time point at which activation commences in a cell or tissue, as opposed to other time points during activation.

As used herein, activation is a process whereby a cell commences its operation from a quiescent (diastolic) state to an active (electrical) state.

In accordance with an embodiment or aspect, a system to reconstruct biological activation information is disclosed. The system includes at least one computing device. The computing device is configured to process a first biological signal and a second biological signal associated with an organ to determine whether there is a point of change in a derivative of the first biological signal with respect to a derivative of the second biological signal above a threshold. The computing device is further configured to assign an activation onset time in the first biological signal at the point of change to define biological activation associated with the organ in the first biological signal if it is determined that the point of change is above the threshold. The point of change can be determined at about the same time point for both the first biological signal and the second biological signal.

The computing device can form a composite biological signal from the first biological signal and the second biological signal, and can determine ratio values at a plurality of points in the first biological signal. Each ratio value can represent a difference between the derivative of the second biological signal and a derivative of the composite biological signal to a difference between the derivative of the first biological signal and the derivative of the composite biological signal. The computing device can also select as the point of change in the first biological signal a point having a largest ratio value from the determined ratio values.

The computing device can match at least one characteristic of the first biological signal to at least one characteristic of a reference biological signal in a catalog of biological signals if it is determined that there is no point of change above the threshold. Thereafter, the computing device can assign an activation onset time in the first biological signal as an onset time of the reference biological signal to define biological activation associated the organ in the first biological signal.

The computing device can iteratively select pairs of biological signals from a plurality of biological signals. Each pair can include a first biological signal and different second biological signal. The computing device can perform processing and assignment for each of the pairs to define multiple biological activations associated with the organ for the first biological signal in each of the pairs. The computing device can further reconstruct a biological activation pattern based on assigned activation onset times of biological activations from the plurality of biological signals to indicate a source of a biological rhythm disorder. The computing device can also display the reconstructed biological activation pattern to facilitate treatment of biological tissue at the source to suppress, lessen or eliminate the biological rhythm disorder.

In accordance with another embodiment or aspect, a method of reconstructing biological activation information is disclosed. The method includes processing a first biological signal and a second biological signal associated with an organ via a computing device to determine whether there is a point of change in a derivative of the first biological signal with respect to a derivative of the second biological signal above a threshold. The method further includes assigning an activation onset time in the first biological signal at the point of change to define biological activation associated with the organ in the first biological signal if it is determined that the point of change is above the threshold. The point of change can be determined at about the same time point for the first biological signal and the second biological signal.

The determination of the point of change in the method can include the following operations. A composite biological signal can be formed from the first biological signal and the second biological signal. Ratio values at a plurality of points in the first biological signal can be determined. Each ratio value can represent a difference between the derivative of the second biological signal and a derivative of the composite biological signal to a difference between derivative of the first biological signal and the derivative of the composite biological signal. A point having a largest ratio value from the determined ratio values can be selected as the point of change in the first biological signal.

If it is determined that there is no point of change above the threshold, the method can include matching at least one characteristic of the first biological signal to at least one characteristic of a reference biological signal in a catalog of biological signals. Thereafter, an activation onset time of the reference biological signal can then be assigned as an activation onset time in the first biological signal to define biological activation associated with the organ in the first biological signal.

The method for reconstructing biological activation information can further include iteratively selecting pairs of biological signals from a plurality of biological signals. Each pair includes a first biological signal and different second biological signal. The operations of processing and assigning for each of the pairs can be performed to define multiple biological activations associated with organ for the first biological signal in each of the pairs. Thereafter, a biological activation pattern can be reconstructed based on assigned activation onset times of biological activations from the plurality of biological signals to indicate a source of a cardiac rhythm disorder.

In accordance with a further embodiment aspect, a method of treating a biological rhythm disorder is disclosed. The method includes iteratively accessing a first biological signal and a second biological signal from a plurality of biological signals associated with an organ. The first biological signal and the second biological signal are processed via a computing device to determine whether there are points of change in a derivative of the first biological signal with respect to a derivative of the second biological signal above a threshold. Activation onset times are assigned to the first biological signal at the points of change to define biological activations associated with the organ in the first biological signal if it is determined that the points of change are above the threshold. The method further includes reconstructing a biological activation pattern based on the assigned activation onset times to indicate a source of the biological rhythm disorder. Still further, the method includes treating organ tissue at the source to suppress or eliminate the biological rhythm disorder.

These and other purposes, goals and advantages of the present application will become apparent from the following detailed description read in connection with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

Some embodiments or aspects are illustrated by way of example and not limitation in the figures of the accompanying drawings in which:

FIG. 1 illustrates an example cardiac activation reconstruction system;

FIG. 2 illustrates an example simple electrogram signal of a heart rhythm disorder from a sensor positioned at a sensor location in a heart illustrated in FIG. 1;

FIG. 3 illustrates an example complex electrogram signal of a heart rhythm disorder from a sensor positioned at a sensor location in a heart illustrated in FIG. 1;

FIG. 4 illustrates an example array of sensors of a catheter illustrated in FIG. 1 and an example selection of signals from the sensors to reconstruct cardiac activation information;

FIG. 5 illustrates example comparison pairs of signals from the sensors of the array illustrated in FIG. 4;

FIG. 6 is an illustration of an example signal pair comparison of analysis signal (SIG1) and reference signal (SIG2);

FIG. 7 is an illustration of another example signal pair comparison of analysis signal (SIG1) and reference signal (SIG2);

FIG. 8 is an illustration of a further example signal pair comparison of analysis signal (SIG1) and reference signal (SIG2) utilizing a composite signal;

FIG. 9 is a flowchart that illustrates an example method of reconstructing cardiac activation information associated with heart rhythm disorders;

FIG. 10 is an illustration of an example signal pair comparison of analysis signal (SIG1) and reference signal (SIG2) that can be processed in accordance with the method of FIG. 9 to reconstruct cardiac activation information;

FIG. 11 is an illustration of an example mapping of processed signals in accordance with FIGS. 1-10; and

FIG. 12 is a block diagram of an illustrative embodiment of a general computer system.

DETAILED DESCRIPTION

A system and method for reconstructing cardiac activation information associated with heart rhythm disorders are disclosed herein. In the following description, for the purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of example embodiments or aspects. It will be evident, however, to one skilled in the art, that an example embodiment may be practiced without all of the disclosed specific details.

FIG. 1 illustrates an example cardiac activation reconstruction system 100. The example system 100 is configured to detect and reconstruct cardiac activation information collected/detected from a patient's heart in connection with a heart rhythm disorder. The heart includes a right atrium 122, left atrium 124, right ventricle 126 and left ventricle 128.

The example system 100 includes a catheter 102, signal processing device 114, computing device 116 and analysis database 118.

The catheter 102 is configured to detect cardiac activation information in the heart and to transmit the detected cardiac activation information to the signal processing device 114, either via a wireless or wired connection. The catheter includes a plurality of probes/sensors 104-112, which can be inserted into the heart through the patient's blood vessels.

In some embodiments or aspects, one or more of the sensors 104-112 are not inserted into the patient's heart. For example, some sensors may detect cardiac activation via the patient's surface (e.g., electrocardiogram) or remotely without contact with the patient (e.g., magnetocardiogram). As another example, some sensors may also derive cardiac activation information from cardiac motion of a non-electrical sensing device (e.g., echocardiogram). In various embodiments or aspects, these sensors can be used separately or in different combinations, and further these separate or different combinations can also be used in combination with sensors inserted into the patient's heart.

The sensors 104-112, which are positioned at sensor locations in the heart under consideration, can detect cardiac activation information at the sensor locations and can further deliver energy to ablate the heart at the sensor locations. It is noted that the sensors 104-112 can also detect cardiac activation information from overlapping regions of the heart (e.g., right atrium 122 and left atrium 124).

The signal processing device 114 is configured to process (e.g., clarify and amplify) the cardiac activation information detected by the sensors 104-112 at the sensor locations into electrogram signals and to provide the processed cardiac signals to the computing device 116 for analysis or processing in accordance with methods disclosed herein. In processing the cardiac activation information from the sensors 104-112, the signal processing device 114 can subtract cardiac activation information from overlapping regions of the heart 120 to provide processed cardiac signals to the computing device 116 for analysis. While in some embodiments or aspects, the signal processing device 114 is configured to provide unipolar signals, in other embodiments or aspects, the signal processing device 114 can provide bipolar signals.

The computing device 116 is configured to receive (or access) cardiac signals from the signal processing device 114 and further configured to analyze or process the cardiac signals in accordance with methods, functions or logic disclosed herein to reconstruct cardiac activation information in the cardiac signals such that it is possible to locate a cause of the heart rhythm disorder and to eliminate the cause.

For example, the computing device 116 can process a first cardiac signal and a second cardiac signal from the received cardiac signals to determine whether there is a point of change in a derivative of the first cardiac signal with respect to a derivative of the second cardiac signal above a threshold. The computing device 116 can then assign an activation onset time in the first signal at the point of change to define cardiac activation indicating a beat in the first signal if it is determined that the point of change is above the threshold.

As another example, the computing device 116 can iteratively select pairs of cardiac signals from the received cardiac signals, each pair having a first cardiac signal and second cardiac signal. The computing device 116 can process and assign for each of the pairs in order to define multiple cardiac activations indicating beats for the first cardiac signal in each of the pairs. For example, the computing device 116 is configured to perform processing and assigning to define multiple cardiac activations indicating beats in the first cardiac signal. The computing device 116 can then reconstruct a cardiac activation pattern based on assigned activation onset times of cardiac activations from the received cardiac signals to indicate a source of a rhythm disorder. In some embodiments or aspects, the computing device 116 can also display the reconstructed cardiac activation pattern to facilitate treatment of cardiac tissue at the source to suppress, lessen or eliminate the cardiac rhythm disorder.

The analysis database 118 is configured to support or aid in the analysis of the signals by the computing device 116. In some embodiments or aspects, the analysis database 118 can store a catalog of reference signals and associated activations to enable the computing device 116 to determine an activation onset associated with a signal being considered (e.g., when point of change is below threshold during a time window), as will be described in greater detail herein.

FIG. 2 illustrates an example simple electrogram signal 200 of a heart rhythm disorder from a sensor positioned at a sensor location in the heart 120. For example, sensor 104 of catheter 102 can be positioned at a sensor location in the right atrium 122, as shown in FIG. 1. As an example, the heart rhythm disorder can be a complex rhythm disorder AF, VF and polymorphic VT, or another heart rhythm disorder.

The example signal 200 is for a time period between about 300 ms and about 900 ms. During this time period, the signal 200 is expected to have four (4) local activation onsets 204-208, e.g., those activation onsets that originate at or near (locally to) the sensor location in the heart 120 of sensor 104. Specifically, based on established observations in heart rhythm disorders, cycle length between activation onsets of about 100 ms to about 300 ms can be expected for AF, and cycle length between activation onsets of about 180 ms to about 240 ms can be expected for complex ventricular arrhythmias. As an example, cycle length 210 of about 100 ms to about 300 is expected between activation onset 202 and activation onset 204. In the example signal 200, the activation onsets 204-208 are generally identifiable as having a small degree of baseline wander superposed in the local signal with few far-field artifacts that could be mistaken as local activity. Local activity in this example can be characterized by an activation onset with a sharp inflection point and high slope, followed by a period of gentle, low-deviation slope representing repolarization, typically lasting between about 100 ms and 250 ms.

In the example signal 200, an example far-field deflection 212 is illustrated between location activation onset 206 and local activation onset 208, e.g., an activation onset that originates at a location in the heart 120 that is different than the sensor location associated with the sensor 104. Specifically, the heart 120 at the sensor location associated with sensor 104 cannot physiologically activate again after activation onset 206 in a shorter cycle than about 100 ms to about 300 ms because local tissue must undergo repolarization. Moreover, the deflection 212 cannot be local to the sensor location associated with the sensor 104 when the deflection 212 is also significantly present in signals collected by neighbor sensors in multiple directions to sensor 104. For example, the far-field deflection 212 detected by sensor 104 can be associated with activation onset at a sensor location associated with sensor 106.

FIG. 3 illustrates an example complex electrogram signal 300 of a heart rhythm disorder from a sensor positioned at a sensor location in the heart 120. For example, sensor 106 of catheter 102 can be positioned at a sensor location in the right atrium 122, as shown in FIG. 1. As an example, the heart rhythm disorder can be a complex rhythm disorder AF, VF and polymorphic VT, or another heart rhythm disorder.

Similarly to example signal 200, example signal 300 is for a time period between about 300 ms and about 900 ms. During this time period, the signal 300 is expected to have four (4) local activation onsets, e.g., activation onsets that originate locally to the sensor location in the heart 120 of sensor 106. However, in the example signal 300 there are eleven (11) possible activation onsets 302-322. Multiple deflections of short duration (shorter than shortest cycle length of about 100 ms) caused by the heart rhythm disorder makes the discernment of local activation onsets at the sensor location of sensor 104 as opposed to far-field activations or simply noise prohibitively difficult.

FIG. 4 illustrates an example array of sensors 400 of catheter 102 and an example selection of signals from the sensors to reconstruct cardiac activation information (e.g., activation onsets). The array 400 includes fifteen (15) example sensors for simplicity and clarity of the description. It is to be understood that the array 400 can include fewer or more sensors to as may be determined to cover different portions of the heart 120. In some embodiments or aspects, the array 400 can include 160 or more sensors.

The sensors of the array 400 are shown in example spatial arrangement with respect to the right atrium 122 of the heart 120. Similarly, the array 400 can be spatially arranged in other chambers of the heart, e.g., left atrium, right ventricle, left ventricle, or for combinations of chambers including the endocardial or epicardial surfaces. In FIG. 4, the spatial arrangement of electrodes in the array 400 is shown to be uniform and planar for simplicity and clarity of the description. However, the heart 120 is not a uniform or planar structure. Accordingly, the spatial arrangement of electrodes in the array 400 can be varied with respect to the shape of the heart 120 to improve detection of electric activity in the heart 120.

In one example embodiment or aspect, catheter 102 of FIG. 1 can be a basket catheter with the example sensors of the array 400 disposed in spatial arrangements along splines 406-408 of the basket catheter 102. Different catheters with various spatial arrangements of the sensors in the sensor array 400 can be used, such as spiral, radial spokes or other spatial arrangements.

Pairs of sensors (signals of sensors) in the array 400 are iteratively selected for processing as will be described in greater detail herein in order to reconstruct cardiac activation information (activation onsets) of the heart 120 in the right atrium 122, or another chamber in which the array 400 may be disposed.

As illustrated at 402, an analysis signal (1) is selected for processing. A reference signal (2)—a neighbor to the analysis signal (1)—is then selected to form a first pair that is processed to determine activation onsets in the analysis signal (1). Similarly, as illustrated at 404, an analysis signal (1) is selected for processing. A reference signal (2)—another neighbor to the analysis signal (1)—is then selected to form a second pair that is processed to determine activation onsets in the analysis signal (1). The activation onsets from the first pair and the second pair of signals can be stored in memory of computing device 116 or database 118 of FIG. 1. The neighboring sensors (signals) can but do not have to be adjacent, as will be described in greater detail below.

The selections and processing are repeated for the sensors of the array 400 (signals) that neighbor the analysis signal (1). The activation onsets in the analysis signal (1) for all pairs of signals can also be stored in memory of computing device 116 or database 118. Thereafter, another analysis signal is selected and the selections and processing are repeated for that analysis signal. In this fashion, each of the plurality of analysis signals in array 400 is processed against its neighboring signals. The number of neighboring signals for a given analysis signal can be fewer or greater depending on the spatial arrangement of the sensors in the array 400, the chamber of the heart analyzed and the heart rhythm disorder treated.

FIG. 5 illustrates example comparison pairs of signals from the sensors of the array 400 illustrated in FIG. 4. Neighbor signals can include not only those signals that are immediately adjacent to the analysis signal but also those signals not adjacent to the analysis signal. Spatially separating the paired sensors can have the effect of spatially extending the area over which deflections are considered to be local activity. Local activity is therefore approximately defined by the separation of the paired sensors. As illustrated in example 1 of FIG. 5, selected analysis signal (1) is processed against adjacent signals (2)-(5) and also against a non-adjacent signal (6). As further illustrated in example 2 of FIG. 5, selected analysis signal (1) is processed against adjacent signals (2)-(5) and also against a non-adjacent signals (6) and (7). While closest neighbor signals are preferred, neighbor signals in various spatial orientations with respect to the analysis signal can be used.

For each analysis signal, there could be a plurality of reference signals (e.g., four (4) reference signals or greater). A final activation onset in the analysis signal is determined with reference to or based on the combination of the reference signals' possible activation onsets. Specifically, the activation onsets determined from each pair can be referenced against each other to check for correspondence or association of activations in the analysis signal. An activation onset for the analysis signal is finalized based on the possible activation onsets of the referenced pairs of signals.

The final activation onset for the analysis signal can be determined in various ways. In one embodiment or aspect, the final activation onset for the analysis signal can be determined based on an average of the possible activation onsets from the various pairs of referenced signals. In another embodiment or aspect, the final activation onset for the analysis signal can be determined based on an average of the possible activation onsets from those pairs of signals in which a majority of the possible activation onsets are within a predetermined time interval of each other (e.g., ±5 ms). The time interval used can be chosen to be lower or higher. Alternatively, the final activation can also be determined by performing a “center-of-mass” calculation weighted by the significance value of each of the possible activation onsets in the majority, or by analysis of a predominant direction of activation onsets relative to sensor locations.

With reference to example 1 in FIG. 5, if an analysis signal has been determined to have possible activation onsets of 170 ms, 190 ms, 193 ms, 165 ms and 172 ms in connection with the five (5) reference signal pairs, respectively, then the final activation onset for the analysis signal can be determined to be (170+165+172)/3=169 ms. The activation onsets of 190 ms and 193 ms that are outside the time interval can be discounted from the determination of the final activation onset for the analysis signal. The final activation onset determined for each signal can be saved in the database 118 of FIG. 1.

While in the forgoing examples for the sake of brevity and clarity, only one activation onset was determined for the analysis signal in connection with each reference signal, it should understood that each signal (from a sensor of array 400) can represent multiple successive analysis intervals (e.g., activation cycles) as illustrated in FIG. 2, each of which can have an activation onset as determined based on the same time interval of multiple reference signals (neighboring sensors of array 400).

FIG. 6 is an illustration of an example signal pair comparison 600 of example analysis signal (SIG1) and example reference signal (SIG2). For example, the signals can be from comparison pair 402 (or comparison pair 404) illustrated in FIG. 4, or from any comparison pair illustrated in FIG. 5. It is noted that the signals are illustrative and occur during the same analysis interval. As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2.

The signals are processed at one or more successive time points (e.g., every millisecond, two milliseconds, or other time points) to determine whether there is a point of change in a derivative of the analysis signal with respect to a derivative of the reference signal above a threshold. The point of change can be determined from one or more of slope, amplitude, timing and shape for the first cardiac signal and the second cardiac signal. It is noted that in some embodiments or aspects, processing of some time points can be omitted (e.g., every other time point or two of three time points). A first derivative (or second derivative can be used) is determined for each of the time points in the signals. A root mean squared is determined for each of the signals. For example, RMS1 and RMS2 are determined by taking a root mean squared of the derivatives for the entire signal of each of the signals (e.g., all activation cycles). RMS can be used to normalize the amplitude of the signals with respect to one another, such that amplitudes (e.g., voltage) of the deflections in the signals do not affect the processing of the signals as described below.

A time point (same time point or about the same time point) is successively selected from each of the signals (SIG1, SIG2) for consideration and processing. For each time point under consideration, a time increment 602, 604 in each signal starting at that time point can be considered. For example, a time increment of 10 ms can be used. Different time increments can be selected. A line which is pinned to the point under consideration in each signal and which provides the best fit to the time points in the time increment of each signal is determined. The determined lines represent the slopes (e.g., volts/per second) of the signals for the selected time point. More specifically, the determined lines represent slopes of the signals at the selected time point for the same time increment (e.g., 10 ms). A significance value (δ) is determined with respect to the slopes.

The significance value can be determined by taking an absolute value of the first slope over its associated root mean squared value and subtracting an absolute value of the second slope over its associated root mean squared value. A determination is made as to whether the resulting (δ)=−0.461 is above a significance threshold (e.g., 0.25). The significance threshold indicates that there is a potentially significant point of change (based on slopes) for the time point in the signals under consideration, e.g., that the derivatives diverge sufficiently from each other. In the example signal pair comparison 600, the significance value (δ)=−0.461 is below the significance threshold of 0.25. The low significance value indicates that the deflection in SIG1 is far-field and not sufficiently local to a sensor location from which the signal originated, e.g., a sensor shown in FIG. 4. Accordingly, there is no potentially significant point of change in the example signal pair comparison 600.

As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2. In each analysis interval, it is possible to have zero, one or more potentially significant points of change as described above. The time point under consideration and the potentially significant point(s) of change can be recorded, such as in database 118.

FIG. 7 is an illustration of an example signal pair comparison 700 of example analysis signal (SIG1) and example reference signal (SIG2). Similarly, the signals can be from comparison pair 402 (or comparison pair 404) illustrated in FIG. 4, or from any comparison pair illustrated in FIG. 5. The signals are illustrative and occur during the same analysis interval. As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2.

The signals are processed at one or more successive time points to determine whether there is a point of change in a derivative of the analysis signal with respect to a derivative of the reference signal above a threshold. In some embodiments or aspects, processing of some time points can be omitted (e.g., every other time point or two of three time points). A first derivative (or second derivative) is determined for each of the time points in the signals. A root mean squared is further determined for each of the signals. A time point (same time point or about the same time point) is successively selected from each of the signals (SIG1, SIG2) for consideration and processing. For each time point under consideration, a time increment 702, 704 (e.g., 10 ms) in each signal starting at that time point can be considered. A line which is pinned to the point under consideration in each signal and which provides the best fit to the time points in the time increment of each signal is determined. The determined lines represent the slopes (e.g., volts/per second) of the signals for the selected time point. More specifically, the determined lines represent the slopes at the selected time point for the same time increment. A significance value (δ) is determined with respect to the slopes.

The significance value can be determined by taking an absolute value of the first slope over its associated root mean squared value and subtracting an absolute value of the second slope over its associated root mean squared value. A determination is made as to whether the resulting (δ)=−0.063 is above a significance threshold (e.g., 0.25). In the example signal pair comparison 700, the significance value (δ)=−0.063 is well below the significance threshold of 0.25. The low significance value indicates low amplitude noise. Accordingly, there is no potentially significant point of change in the example signal pair comparison 700.

A noise level can be defined as fraction of the significance threshold or can be defined programmatically in various ways. For example, noise level can be one-tenth (0.025) of the significance threshold (0.25). A different fraction level can be selected. As another example, the noise level can be defined as a Gaussian standard deviation of a plurality of significance values. Other ways of defining the noise level are contemplated. It is noted that the significance threshold (e.g., 0.25) is higher than the noise level that can be associated with the analysis signal and reference signal in the example signal pair comparison 700. Accordingly, a point of change at or below noise level can be associated with one or more signals from other regions of a heart, respiratory system, gastrointestinal tract, neurological system as well as electronic interference.

As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles) and in each analysis interval, it is possible to have zero, one or more potentially significant points of change as described above. The time point under consideration and the potentially significant point(s) of change can be recorded, such as in database 118.

FIG. 8 is an illustration of an example signal pair comparison 800 of example analysis signal (SIG1) and example reference signal (SIG2) utilizing a composite signal. As in the other examples, the signals can be from comparison pair 402 (or comparison pair 404) illustrated in FIG. 4, or from any comparison pair illustrated in FIG. 5. The signals are illustrative and occur during the same analysis interval. As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2.

The signals are processed at one or more successive time points to determine whether there is a point of change in a derivative of the analysis signal with respect to a derivative of the reference signal above a threshold. In some embodiments or aspects, processing of some time points can be omitted (e.g., every other time point or two of three time points). A first derivative (zero order derivative or second derivative) is determined for each of the time points in the signals. A root mean squared is further determined for each of the signals. A time point (same time point or about the same time point) is successively selected from each of the signals (SIG1, SIG2) for consideration and processing. For each time point under consideration, a time increment 802, 804 (e.g., 10 ms) in each signal starting at that time point can be used. A line which is pinned to the point under consideration in each signal and which provides the best fit to the time points in the time increment of each signal is determined. The determined lines represent the slopes (e.g., volts/per second) of the signals for the selected time point. More specifically, the determined lines represent the slopes of the signals at the selected time point for same time increment. A significance value (δ) is determined with respect to the slopes.

In some embodiments or aspects, the significance value can be determined by taking an absolute value of the first slope over its associated root mean squared value and subtracting an absolute value of the second slope over its associated root mean squared value. A determination is made as to whether the resulting (δ)=0.546 is above a significance threshold (e.g., 0.25). In the example signal pair comparison 800, the significance value (δ)=0.546 is determined to be above the significance threshold of 0.25.

Accordingly, there is a potentially significant point of change in the example signal pair comparison 800 at the time point under consideration. As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles) and in each analysis interval, it is possible to have zero, one or more potentially significant points of change as described above. The time point under consideration and the potentially significant point(s) of change can be recorded, such as in database 118.

In other embodiments or aspects, the significance value can be determined with respect to a composite signal. Specifically, a composite signal (COMP) is computed by subtracting SIG2 (reference signal) from SIG1 (analysis signal), e.g., COMP=SIG2−SIG1. The composite signal can represent a bipolar signal (COMP) of constituent unipolar signals (SIG1, SIG2). In alternate embodiments or aspects, the composite signal COMP can also be computed by adding signals SIG1 and SIG2. The signals in the signal pair comparison 800 are illustrative and occur during the same analysis interval. As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2.

The signals SIG1, SIG2 are processed at one or more successive time points with respect to the composite signal COMP to determine whether there is a point of change in a derivative of the analysis signal with respect to a derivative of the reference signal above a threshold. A first derivative (or second derivative) is determined for each of the time points in the signals, SIG1, SIG2, COMP. A time point (same time point or about the same time point) is successively selected from each of the signals (SIG1, SIG2, COMP) for consideration and processing. For each time point under consideration, a time increment 802, 804, 806 (e.g., 10 ms) in each signal starting at that time point can be considered. A line which is pinned to the point under consideration in each signal and which provides the best fit to the time points in the time increment of each signal is determined. The determined lines represent the slopes (e.g., volts/per second) of the signals for the selected time point. More specifically, the determined lines represent the slopes of the signals at the selected time point for the same time increment. A significance value (δ) is determined with respect to the slopes.

In the embodiments or aspects employing the composite signal, the significance value (δ) can be determined by a ratio taking an absolute value of the second slope and subtracting an absolute value of the composite slope, and dividing by a logarithm of a result of an absolute value the first slope subtracting an absolute value of the composite slope. The resulting significance value for the time point under consideration is (δ)=31.63. Significance values can be computed for all points under consideration. A significance threshold can be determined to be an average of the computed significance values (δ) plus a standard deviation. Thereafter, only those significance values (δ) that are above the significance threshold can be considered to be potentially significant points of change for the comparison pair 800. For the example signals in the signal pair comparison 800 of FIG. 8, the determined significance threshold can be 10. It is noted that the significance value(s) that is above the significance threshold generally extends substantially above the significance threshold. For example, a significance value (δ)—having the largest ratio—can therefore be selected.

Accordingly, there is a potentially significant point of change in the example signal pair comparison 800 at the time point under consideration. As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles) and in each analysis interval, it is possible to have zero, one or more potentially significant points of change as described above. The time point under consideration and the potentially significant point(s) of change can be recorded, such as in database 118.

FIG. 9 is a flowchart that illustrates an example method 900 of reconstructing cardiac activation information (activation onset) associated with heart rhythm disorders. The example method 900 can be performed by the computing device 116 illustrated in FIG. 1. More specifically, the example method 900 starts at operation 902 at which signals are received by the computing device 116 via signal processing device 114 from sensors disposed in the heart 120. For example, signals can be received from sensors of the sensor array 400 disposed in the right atrium 122 of the heart 120, as shown in FIGS. 1 and 4. In some embodiments or aspects, at least a portion of the signals from the sensors can be recorded by signal processing device 114 and then provided to computing device 116.

At operation 904, a first signal (analysis signal) is selected. At operation 906, a second signal (reference signal) is selected. Selection of the analysis signal and the reference signal can be performed as described in greater detail with reference to FIGS. 4 and 5. In some embodiments or aspects, a root mean squared (RMS) can be determined for the first signal and for the second signal. At operation 908, a time interval over which the first signal and the second signal are to be compared is selected. The time interval can be selected to be an activation cycle (e.g., 100 ms to 300 ms) as described in FIG. 2. In some embodiments or aspects, the time interval can be determined by a dominant frequency analysis or other analysis of the average cycle length of the first (analysis) signal. A default time interval of 200 ms can be used if the time interval cannot be determined computationally. In other embodiments or aspects, the time interval can be selected manually, computationally by a different analysis method, from a database that catalogs such time intervals for patients of a certain age, gender and type of heart rhythm disorder, or defaulted to a value between about 100 ms and about 300 ms.

In some embodiments or aspects, a composite signal can be determined based on the selected first signal and the second signal, such as by subtracting or adding the signals as described with reference to FIG. 8.

At operation 910, a time point is selected for consideration in the selected time interval. The same or about the same time point is selected for consideration in each signal (e.g., first signal and second signal). At operation 912, derivatives are calculated for a time increment (e.g., 10 ms) extending from the point of consideration in each signal. In those embodiments or aspects that use a composite signal, a derivative is also calculated for a time increment (e.g., 10 ms) extending from a time point of consideration in the composite signal. The time point of consideration in the composite signal is the same or about the same as in the other signals (e.g., first signal and second signal).

At operation 914, a determination is made as to whether all points in the selected time interval have been processed. If it is determined that all point in the selected time interval were processed, the method 900 continues at operation 916. Alternatively, the method 900 performs operations 910, 912 until all points in the selected time interval are determined to be processed at operation 914.

At operation 916, points of change between the derivatives of the first signal with respect to the derivatives of the second signal are determined in the time interval under consideration. For example, a significance value (δ) can be determined at each point of change as described with reference to FIGS. 6-8.

At operation 918, a determination is made as to whether there is a point(s) of change in the derivative of the first cardiac signal with respect to the derivative of the second cardiac signal above a threshold. For example, it can be determined whether the significance value (δ) at the point of change is above the threshold. In some embodiments or aspects that do not use a composite signal, the threshold can be 0.25 (or another value) as described with reference to FIGS. 6-8, while in those embodiments or aspects that use a composite signal, the threshold can be computed as an average value plus a standard deviation of all points of change as described with reference to FIG. 8.

If it is determined that there is a point(s) of change above the threshold, the method 900 continues at operation 920 where the significant point(s) of change is recorded (selected) as a possible activation onset(s) for the time interval under consideration in the first (analysis) signal. If however, it is determined that there is no point of change above the threshold (no significant point of change), the method 900 continues at operation 924 where the first signal is compared over the time interval to a catalog of reference signals. For example, the catalog of reference signals for heart rhythm disorders can be maintained in database 118. At operation 926, a determination is made as to whether there is a match to a reference signal in the database. The comparison can be based on at least one characteristic of the first signal to at least one characteristic of the reference signal, such as shape, slope, amplitude, frequency and/or timing. Other characteristics can be used together with or instead of the enumerated characteristics.

If there is no match to a reference signal at operation 926, the method 900 continues at operation 922. Alternatively, the method 900 continues at operation 928 where the point(s) of change in the time interval under consideration is recorded (selected), which would correspond to activation onset(s) in the reference signal that was matched.

At operation 922, a determination is made as to whether all time intervals in the signals have been processed. If it is determined that all time intervals have not been processed, the method 900 continues to perform operations 908-922 to process subsequent time intervals until it is determined that all time intervals have been processed. The subsequent time interval can be determined from the point(s) of change that represents the possible activation onset at 920. Specifically, if only one point of change (above the threshold) is recorded at 920, then the next time interval (e.g., 100 ms to 300 ms) starts at the onset time associated with the point of change plus a half of a cycle length (e.g., 50 ms to 150 ms). If there are multiple points of change, then the onset time associated with the largest point of change (significance value) is used to determine the next time interval for operations 908-922. It is noted that the determination of the next time interval can be extended to consider significant points of change from all second (reference) signals for the same time interval under consideration. However, if it is determined that all time intervals have been processed at operation 922, the method 900 continues at operation 930.

At operation 930, a determination is made as to whether all second (reference) signals have been processed in association with the selected first (analysis signal. If it is determined that all second signals have not been processed, the method 900 continues to perform operations 906-930 until it is determined that all second (reference) signals have been processed for the first (analysis) signal. However, if it is determined that all second signals have been processed, the method 900 continues to operation 932.

At operation 932, an activation onset(s) is assigned in the first signal at the point(s) of change to define cardiac activation(s) indicating a beat(s) in the first signal if it is determined (at operation 918) that the point(s) of change is above the threshold. Similarly, at operation 932 an activation onset(s) can be assigned in the first signal at the point(s) of change to define cardiac activation(s) indicating a beat(s) in the first signal based on a matched reference signal (at operation 928). More specifically, activation onsets are assigned to the time intervals of the first signal based on the recorded (or significant) point(s) of change of the first signal with reference to the second signal(s). That is, an activation onset is assigned to each time interval in the first (analysis) signal based possible activation onset(s) associated with the significant point(s) of change in the same time interval of the second (reference) signal(s). As described with reference to FIG. 5, the activation onset for the time interval of the first (analysis) signal can be determined based on an average of the activation onsets with reference to the second (reference) signals. In another embodiment or aspect, the activation onset for the time interval of the first signal can be determined based on an average of activation onsets with reference to those second signals in which a majority of activation onsets are within a predetermined time interval of each other (e.g., ±5 ms). The assigned onset can be recorded for each interval in the first (analysis) signal such as in database 118.

At operation 934, a determination is made as to whether all signals have been processed or analyzed as first (analysis) signals against second (reference) signals. If it is determined that all signals have not been processed, then the method 900 continues to perform operations 904-932 until all signals have been processed. Alternatively, if it is determined that all signals have been processed, the method 900 ends at operation 936.

At the conclusion of the method 900, signals collected from the heart 120 have been reconstructed with cardiac activation information (activation onsets) such that a cause of the heart rhythm disorder can be determined. More specifically, unipolar electrograms or monophasic action potentials (MAPs) can be mapped to the reconstructed activation onsets of the signals to show unipolar or MAP sequences or representations for the signals. An activation map or pattern can be constructed from these unipolar voltage or MAP voltage representations of the signals to locate the cause of the heart rhythm disorder. An example MAP representation and example activation map are illustrated in FIG. 11.

FIG. 10 is an illustration of an example signal pair comparison 1000 of analysis signal (SIG1) and reference signal (SIG2) that can be processed in accordance with method 900 of FIG. 9 to assign an activation onset 1004. As illustrated in comparison 1000, a time interval 1002 (e.g., 100 ms-300 ms) is selected for comparison and processing. In some example embodiments or aspects, the signals in the time interval (SIG1, SIG2, COMP) are smoothed, such as via median filter. Significance values (δ) are determined for the points of changes in the signals' first or second derivative, as described herein with reference to FIGS. 1-9. As illustrated in signal pair comparison 1000, point of change 1012 in SIG1 that is above threshold 1010 is assigned as the activation onset 1004 for the time interval 1002 in SIG1 based on the first derivative. Alternatively, point of change 1014 in SIG1 that is above threshold 1010 is assigned as the activation onset 1004 for the time interval 1002 in SIG1 based on the second derivative. Subsequent time intervals are selected and activation onsets are assigned as described herein with reference to FIGS. 1-9 until the analysis signal (SIG1) is processed.

FIG. 11 is an illustration of an example mapping 1100 of processed signals in accordance with FIGS. 1-10. Raw signal 1100 represents a signal that is processed to assign activation onsets (vertical lines) as described herein. For reference purposes, a composite signal 1102 is shown, which results from the raw (analysis) signal 1100 and another (reference) signal (not shown). A monophasic action potential (MAP) voltage representation is generated from for each processed signal 1100. Multiple signals are processed as described herein and MAPs generated based on the processed signals. The electrical activity of all MAPs is mapped in a sequence of example activation mappings 1106 to show activation onsets 1108, 1110, 1112 and 1114 at each time interval, respectively. These mappings can be displayed by computing device 116. Although only four mapping are shown for illustrative purposes, there can be fewer or greater number of mappings 1106 based on the time intervals represented in the signals.

As shown by the arrows in the example mappings 1106 (e.g., activation onsets 1108-1114), the electrical activity indicates a rotational activation pattern of activation onsets (rotor) in the heart rhythm disorder. At least a portion of the area of the heart 120 indicated by the rotational activation pattern indicated by the arrows in FIG. 11 can be treated to eliminate the cause of the heart rhythm disorder, and therefore the heart rhythm disorder itself. Such treatment may be delivered by ablation using various energy sources (including but not limited to radiofrequency, cryoenergy, microwave, and ultrasound), gene therapy, stem cell therapy, pacing stimulation, drug or other therapy. It is noted that the MAP representation and activation map are examples to illustrate a rotational activation pattern. Other activation patterns can result from different example signals collected by the sensors from the heart 120.

FIG. 12 is a block diagram of an illustrative embodiment of a general computer system 1200. The computer system 1200 can be the signal processing device 114 and the computing device 116 of FIG. 1. The computer system 1200 can include a set of instructions that can be executed to cause the computer system 12800 to perform any one or more of the methods or computer based functions disclosed herein. The computer system 1200, or any portion thereof, may operate as a standalone device or may be connected, e.g., using a network or other connection, to other computer systems or peripheral devices. For example, the computer system 1200 may be operatively connected to signal processing device 114 and analysis database 118.

The computer system 1200 may also be implemented as or incorporated into various devices, such as a personal computer (PC), a tablet PC, a personal digital assistant (PDA), a mobile device, a palmtop computer, a laptop computer, a desktop computer, a communications device, a control system, a web appliance, or any other machine capable of executing a set of instructions (sequentially or otherwise) that specify actions to be taken by that machine. Further, while a single computer system 1200 is illustrated, the term “system” shall also be taken to include any collection of systems or sub-systems that individually or jointly execute a set, or multiple sets, of instructions to perform one or more computer functions.

As illustrated in FIG. 12, the computer system 1200 may include a processor 1202, e.g., a central processing unit (CPU), a graphics-processing unit (GPU), or both. Moreover, the computer system 1200 may include a main memory 1204 and a static memory 1206 that can communicate with each other via a bus 1226. As shown, the computer system 1200 may further include a video display unit 1210, such as a liquid crystal display (LCD), an organic light emitting diode (OLED), a flat panel display, a solid state display, or a cathode ray tube (CRT). Additionally, the computer system 1200 may include an input device 1212, such as a keyboard, and a cursor control device 1214, such as a mouse. The computer system 1200 can also include a disk drive unit 1216, a signal generation device 1222, such as a speaker or remote control, and a network interface device 1208.

In a particular embodiment or aspect, as depicted in FIG. 12, the disk drive unit 1216 may include a computer-readable medium 1218 in which one or more sets of instructions 1220, e.g., software, can be embedded. Further, the instructions 1220 may embody one or more of the methods or logic as described herein. In a particular embodiment or aspect, the instructions 1220 may reside completely, or at least partially, within the main memory 1204, the static memory 1206, and/or within the processor 1202 during execution by the computer system 1200. The main memory 1204 and the processor 1202 also may include computer-readable media.

In an alternative embodiment or aspect, dedicated hardware implementations, such as application specific integrated circuits, programmable logic arrays and other hardware devices, can be constructed to implement one or more of the methods described herein. Applications that may include the apparatus and systems of various embodiments or aspects can broadly include a variety of electronic and computer systems. One or more embodiments or aspects described herein may implement functions using two or more specific interconnected hardware modules or devices with related control and data signals that can be communicated between and through the modules, or as portions of an application-specific integrated circuit. Accordingly, the present system encompasses software, firmware, and hardware implementations.

In accordance with various embodiments or aspects, the methods described herein may be implemented by software programs tangibly embodied in a processor-readable medium and may be executed by a processor. Further, in an exemplary, non-limited embodiment or aspect, implementations can include distributed processing, component/object distributed processing, and parallel processing. Alternatively, virtual computer system processing can be constructed to implement one or more of the methods or functionality as described herein.

It is also contemplated that a computer-readable medium includes instructions 1220 or receives and executes instructions 1220 responsive to a propagated signal, so that a device connected to a network 1224 can communicate voice, video or data over the network 1224. Further, the instructions 1220 may be transmitted or received over the network 1224 via the network interface device 1208.

While the computer-readable medium is shown to be a single medium, the term “computer-readable medium” includes a single medium or multiple media, such as a centralized or distributed database, and/or associated caches and servers that store one or more sets of instructions. The term “computer-readable medium” shall also include any medium that is capable of storing, encoding or carrying a set of instructions for execution by a processor or that cause a computer system to perform any one or more of the methods or operations disclosed herein.

In a particular non-limiting, example embodiment or aspect, the computer-readable medium can include a solid-state memory, such as a memory card or other package, which houses one or more non-volatile read-only memories. Further, the computer-readable medium can be a random access memory or other volatile re-writable memory. Additionally, the computer-readable medium can include a magneto-optical or optical medium, such as a disk or tapes or other storage device to capture carrier wave signals, such as a signal communicated over a transmission medium. A digital file attachment to an e-mail or other self-contained information archive or set of archives may be considered a distribution medium that is equivalent to a tangible storage medium. Accordingly, any one or more of a computer-readable medium or a distribution medium and other equivalents and successor media, in which data or instructions may be stored, are included herein.

In accordance with various embodiments or aspects, the methods described herein may be implemented as one or more software programs running on a computer processor. Dedicated hardware implementations including, but not limited to, application specific integrated circuits, programmable logic arrays, and other hardware devices can likewise be constructed to implement the methods described herein. Furthermore, alternative software implementations including, but not limited to, distributed processing or component/object distributed processing, parallel processing, or virtual machine processing can also be constructed to implement the methods described herein.

It should also be noted that software that implements the disclosed methods may optionally be stored on a tangible storage medium, such as: a magnetic medium, such as a disk or tape; a magneto-optical or optical medium, such as a disk; or a solid state medium, such as a memory card or other package that houses one or more read-only (non-volatile) memories, random access memories, or other re-writable (volatile) memories. The software may also utilize a signal containing computer instructions. A digital file attachment to e-mail or other self-contained information archive or set of archives is considered a distribution medium equivalent to a tangible storage medium. Accordingly, a tangible storage medium or distribution medium as listed herein, and other equivalents and successor media, in which the software implementations herein may be stored, are included herein.

Thus, system and method to reconstruct cardiac activation information have been described. Although specific example embodiments or aspects have been described, it will be evident that various modifications and changes may be made to these embodiments or aspects without departing from the broader scope of the invention. Accordingly, the specification and drawings are to be regarded in an illustrative rather than a restrictive sense. The accompanying drawings that form a part hereof, show by way of illustration, and not of limitation, specific embodiments or aspects in which the subject matter may be practiced. The embodiments or aspects illustrated are described in sufficient detail to enable those skilled in the art to practice the teachings disclosed herein. Other embodiments or aspects may be utilized and derived therefrom, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. This Detailed Description, therefore, is not to be taken in a limiting sense, and the scope of various embodiments or aspects is defined only by the appended claims, along with the full range of equivalents to which such claims are entitled.

Such embodiments or aspects of the inventive subject matter may be referred to herein, individually and/or collectively, by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept if more than one is in fact disclosed. Thus, although specific embodiments or aspects have been illustrated and described herein, it should be appreciated that any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments or aspects shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments or aspects. Combinations of the above embodiments or aspects, and other embodiments or aspects not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.

The Abstract is provided to comply with 37 C.F.R. §1.72(b) and will allow the reader to quickly ascertain the nature and gist of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.

In the foregoing description of the embodiments or aspects, various features are grouped together in a single embodiment for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting that the claimed embodiments or aspects have more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment or aspect. Thus the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate example embodiment or aspect. It is contemplated that various embodiments or aspects described herein can be combined or grouped in different combinations that are not expressly noted in the Detailed Description. Moreover, it is further contemplated that claims covering such different combinations can similarly stand on their own as separate example embodiments or aspects, which can be incorporated into the Detailed Description.

Claims (20)

What is claimed is:
1. A method of reconstructing biological activation information, the method comprising:
processing a first biological signal and a second biological signal associated with an organ via a computing device to determine whether there is a point of change in a derivative of the first biological signal with respect to a derivative of the second biological signal above a threshold; and
assigning an activation onset time in the first biological signal at the point of change to define biological activation associated with the organ in the first biological signal if it is determined that the point of change is above the threshold.
2. The method of claim 1, wherein the point of change is determined at about the same time point for the first biological signal and the second biological signal.
3. The method of claim 1, wherein the point of change is determined from one or more of slope, amplitude, timing and shape for the first biological signal and the second biological signal.
4. The method of claim 1, wherein determination of the point of change comprises:
forming a composite biological signal from the first biological signal and the second biological signal;
determining ratio values at a plurality of points in the first biological signal, each ratio value representing a difference between the derivative of the second biological signal and a derivative of the composite biological signal to a difference between derivative of the first biological signal and the derivative of the composite biological signal; and
selecting as the point of change in the first biological signal a point having a largest ratio value from the determined ratio values.
5. The method of claim 1, wherein the threshold is higher than a noise level associated with the first biological signal and the second biological signal.
6. The method of claim 5, wherein a point of change at or below the noise level is associated with one or more signals from a heart, respiratory system, gastrointestinal tract, neurological system and electronic interference.
7. The method of claim 1, further comprising:
matching at least one characteristic of the first biological signal to at least one characteristic of a reference biological signal in a catalog of biological signals if it is determined that there is no point of change above the threshold; and
assigning an activation onset time in the first biological signal as an activation onset time of the reference biological signal to define biological activation associated with the organ in the first biological signal.
8. The method of claim 1, further comprising performing processing and assigning to define multiple biological activations associated with the organ in the first biological signal.
9. The method of claim 1, further comprising iteratively selecting the first biological signal and the second biological signal from a plurality of biological signals.
10. The method of claim 1, further comprising:
iteratively selecting pairs of biological signals from a plurality of biological signals, each pair having a first biological signal and different second biological signal;
performing processing and assigning for each of the pairs to define multiple biological activations associated with the organ for the first biological signal in each of the pairs; and
reconstructing a biological activation pattern based on assigned activation onset times of biological activations from the plurality of biological signals to indicate a source of a biological rhythm disorder.
11. A system to reconstruct biological activation information comprising: at least one computing device configured to:
process a first biological signal and a second biological signal associated with an organ to determine whether there is a point of change in a derivative of the first biological signal with respect to a derivative of the second biological signal above a threshold; and
assign an activation onset time in the first biological signal at the point of change to define biological activation associated with the organ in the first biological signal if it is determined that the point of change is above the threshold.
12. A system of claim 11, further comprising a computer readable medium comprising instructions, which when executed by the at least one computing device, cause the at least one computing device to process and assign.
13. The system of claim 11, wherein the point of change is determined at about the same time point for both the first biological signal and the second biological signal.
14. The system of claim 11, wherein the at least one computing device is further configured to:
form a composite biological signal from the first biological signal and the second biological signal;
determine ratio values at a plurality of points in the first biological signal, each ratio value representing a difference between the derivative of the second biological signal and a derivative of the composite biological signal to a difference between the derivative of the first biological signal and the derivative of the composite biological signal; and
select as the point of change in the first biological signal a point having a largest ratio value from the determined ratio values.
15. The system of claim 11, wherein the at least one computing device is further configured to:
match at least one characteristic of the first biological signal to at least one characteristic of a reference biological signal in a catalog of biological signals if it is determined that there is no point of change above the threshold; and
assign an activation onset time in the first biological signal as an onset time of the reference biological signal to define biological activation associated with the organ in the first biological signal.
16. The system of claim 11, wherein the at least one computing device is further configured to perform processing and assigning to define multiple biological activations associated with the organ in the first biological signal.
17. The system of claim 11, wherein the at least one computing device is further configured to iteratively select the first biological signal and the second biological signal from a plurality of biological signals.
18. The system of claim 11, further comprising a catheter with at least a first sensor and a second sensor to detect the first biological signal and the second biological signal, respectively.
19. The system of claim 11, wherein the at least one computing device is further configured to:
iteratively select pairs of biological signals from a plurality of biological signals, each pair having a first biological signal and different second biological signal;
process and assign for each of the pairs to define multiple biological activations associated with the organ for the first biological signal in each of the pairs;
reconstruct a biological activation pattern based on assigned activation onset times of biological activations from the plurality of biological signals to indicate a source of a biological rhythm disorder; and
display the reconstructed biological activation pattern to facilitate treatment of organ tissue at the source to suppress, lessen or eliminate the biological rhythm disorder.
20. A method of treating a biological rhythm disorder, the method comprising:
iteratively accessing a first biological signal and a second biological signal from a plurality of biological signals associated with an organ;
processing the first biological signal and the second biological signal via a computing device to determine whether there are points of change in a derivative of the first biological signal with respect to a derivative of the second biological signal above a threshold;
assigning activation onset times to the first biological signal at the points of change to define biological activations associated with the organ in the first biological signal if it is determined that the points of change are above the threshold;
reconstructing a biological activation pattern based on the assigned activation onset times to indicate a source of the biological rhythm disorder; and
treating organ tissue at the source to suppress or eliminate the biological rhythm disorder.
US13438534 2011-05-02 2012-04-03 System and method for reconstructing cardiac activation information Active US8594777B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US201161481607 true 2011-05-02 2011-05-02
US13217123 US8165666B1 (en) 2011-05-02 2011-08-24 System and method for reconstructing cardiac activation information
US13438534 US8594777B2 (en) 2011-05-02 2012-04-03 System and method for reconstructing cardiac activation information

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US13438534 US8594777B2 (en) 2011-05-02 2012-04-03 System and method for reconstructing cardiac activation information
US13840334 US9050006B2 (en) 2011-05-02 2013-03-15 System and method for reconstructing cardiac activation information
US14074619 US9055876B2 (en) 2011-05-02 2013-11-07 System and method for reconstructing cardiac activation information
US14077250 US9055877B2 (en) 2011-05-02 2013-11-12 System and method for reconstructing cardiac activation information
PCT/US2014/029616 WO2014144983A3 (en) 2011-05-02 2014-03-14 System and method for reconstructing cardiac activation information
US14473572 US9107600B2 (en) 2011-05-02 2014-08-29 System and method for reconstructing cardiac activation information
US14473905 US9055878B2 (en) 2011-05-02 2014-08-29 System and method for reconstructing cardiac activation information
US14670300 US9220427B2 (en) 2011-05-02 2015-03-26 System and method for reconstructing cardiac activation information
US14724621 US9468387B2 (en) 2011-05-02 2015-05-28 System and method for reconstructing cardiac activation information
US14798363 US9398883B2 (en) 2011-05-02 2015-07-13 System and method for reconstructing cardiac activation information
US14944096 US9668666B2 (en) 2011-05-02 2015-11-17 System and method for reconstructing cardiac activation information
US15204455 US20170007176A1 (en) 2011-05-02 2016-07-07 System and method for reconstructing cardiac activation information
US15244792 US20160360983A1 (en) 2011-05-02 2016-08-23 System and method for reconstructing cardiac activation information
US15344230 US9913615B2 (en) 2011-05-02 2016-11-04 System and method for reconstructing cardiac activation information

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13217123 Continuation US8165666B1 (en) 2011-05-02 2011-08-24 System and method for reconstructing cardiac activation information

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US13840334 Continuation-In-Part US9050006B2 (en) 2011-05-02 2013-03-15 System and method for reconstructing cardiac activation information
US14074619 Continuation US9055876B2 (en) 2011-05-02 2013-11-07 System and method for reconstructing cardiac activation information
US14077250 Continuation US9055877B2 (en) 2011-05-02 2013-11-12 System and method for reconstructing cardiac activation information

Publications (2)

Publication Number Publication Date
US20120283579A1 true US20120283579A1 (en) 2012-11-08
US8594777B2 true US8594777B2 (en) 2013-11-26

Family

ID=45953574

Family Applications (7)

Application Number Title Priority Date Filing Date
US13217123 Active US8165666B1 (en) 2011-05-02 2011-08-24 System and method for reconstructing cardiac activation information
US13438534 Active US8594777B2 (en) 2011-05-02 2012-04-03 System and method for reconstructing cardiac activation information
US14074619 Active US9055876B2 (en) 2011-05-02 2013-11-07 System and method for reconstructing cardiac activation information
US14077250 Active US9055877B2 (en) 2011-05-02 2013-11-12 System and method for reconstructing cardiac activation information
US14473905 Active US9055878B2 (en) 2011-05-02 2014-08-29 System and method for reconstructing cardiac activation information
US14724621 Active US9468387B2 (en) 2011-05-02 2015-05-28 System and method for reconstructing cardiac activation information
US15244792 Pending US20160360983A1 (en) 2011-05-02 2016-08-23 System and method for reconstructing cardiac activation information

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13217123 Active US8165666B1 (en) 2011-05-02 2011-08-24 System and method for reconstructing cardiac activation information

Family Applications After (5)

Application Number Title Priority Date Filing Date
US14074619 Active US9055876B2 (en) 2011-05-02 2013-11-07 System and method for reconstructing cardiac activation information
US14077250 Active US9055877B2 (en) 2011-05-02 2013-11-12 System and method for reconstructing cardiac activation information
US14473905 Active US9055878B2 (en) 2011-05-02 2014-08-29 System and method for reconstructing cardiac activation information
US14724621 Active US9468387B2 (en) 2011-05-02 2015-05-28 System and method for reconstructing cardiac activation information
US15244792 Pending US20160360983A1 (en) 2011-05-02 2016-08-23 System and method for reconstructing cardiac activation information

Country Status (8)

Country Link
US (7) US8165666B1 (en)
EP (2) EP3001949A1 (en)
JP (1) JP5475926B2 (en)
KR (1) KR20140066125A (en)
CN (4) CN103813747B (en)
CA (1) CA2834944A1 (en)
RU (1) RU2013153107A (en)
WO (1) WO2012151008A3 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130226016A1 (en) * 2011-05-02 2013-08-29 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US20140066787A1 (en) * 2011-05-02 2014-03-06 Topera, Inc. System and method for reconstructing cardiac activation information
US20140371614A1 (en) * 2011-05-02 2014-12-18 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9089269B2 (en) 2010-04-08 2015-07-28 The Regents Of The University Of California System and method for reconstructing cardiac signals associated with a complex rhythm disorder
US9282910B2 (en) 2011-05-02 2016-03-15 The Regents Of The University Of California System and method for targeting heart rhythm disorders using shaped ablation
US9332915B2 (en) 2013-03-15 2016-05-10 The Regents Of The University Of California System and method to identify sources associated with biological rhythm disorders
US9375156B2 (en) 2008-10-09 2016-06-28 The Regents Of The University Of California System for analysis of complex rhythm disorders
US9392948B2 (en) 2011-12-09 2016-07-19 The Regents Of The University Of California System and method of identifying sources for biological rhythms
US9393425B2 (en) 2008-05-13 2016-07-19 The Regents Of The University Of California Methods and systems for detecting and treating heart instability

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2831116C (en) 2011-04-22 2015-04-14 Topera, Inc. Basket style cardiac mapping catheter having spline bends for detection of cardiac rhythm disorders
EP2967399A4 (en) * 2013-03-15 2016-11-23 Univ California System and method for reconstructing cardiac activation information
CN106714677A (en) * 2014-08-29 2017-05-24 加利福尼亚大学董事会 System and method for reconstructing cardiac activation information
US9295399B2 (en) 2012-06-20 2016-03-29 Intermountain Invention Management, Llc Atrial fibrillation treatment systems and methods
US20130345583A1 (en) * 2012-06-20 2013-12-26 Boston Scientific Scimed, Inc. Suppression of global activity during multi-channel electrophysiology mapping using a whitening filter
CN104717918B (en) * 2012-06-20 2017-07-04 波士顿科学医学有限公司 During electrophysiological mapping enhanced signal vector analysis to inhibit activated globally
US9681817B2 (en) 2012-12-20 2017-06-20 Boston Scientific Scimed, Inc. Suppression of global activation signals during anatomical mapping
US9439578B2 (en) 2012-12-27 2016-09-13 Boston Scientific Scimed, Inc. Artifact cancellation to suppress far-field activation during electrophysiology mapping
US9089272B2 (en) * 2013-01-02 2015-07-28 Boston Scientific Scimed Inc. Estimating restitution curves in an anatomical mapping system
EP3125756A4 (en) * 2014-04-01 2017-12-13 Univ California System and method of identifying sources associated with biological rhythm disorders
US8715199B1 (en) 2013-03-15 2014-05-06 Topera, Inc. System and method to define a rotational source associated with a biological rhythm disorder
JP6117433B2 (en) * 2013-05-16 2017-04-19 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Mapping system for optimization of activity start time that is enhanced by the similarity-based pattern matching
JP2016530008A (en) 2013-08-28 2016-09-29 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Predicting the prevalence of activation patterns in the data segment in electrophysiological mapping
US20150073721A1 (en) * 2013-09-12 2015-03-12 Topera, Inc. System and method to select signal segments for analysis of a biological rhythm disorder
CN105636513A (en) 2013-10-31 2016-06-01 波士顿科学医学有限公司 Medical device for high resolution mapping using localized matching
EP3094243A1 (en) * 2014-01-13 2016-11-23 Boston Scientific Scimed, Inc. Medical devices for mapping cardiac tissue
US9532725B2 (en) 2014-03-07 2017-01-03 Boston Scientific Scimed Inc. Medical devices for mapping cardiac tissue
WO2015138167A1 (en) 2014-03-11 2015-09-17 Boston Scientific Scimed, Inc. Medical devices for mapping cardiac tissue
US9986921B2 (en) 2014-05-01 2018-06-05 Worcester Polytechnic Institute Detection and monitoring of atrial fibrillation
JP2017521200A (en) 2014-06-03 2017-08-03 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for the mapping of the heart tissue
JP2017521117A (en) 2014-06-20 2017-08-03 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for the mapping of the heart tissue

Citations (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5121750A (en) 1990-03-02 1992-06-16 Katims Jefferson J Apparatus for locating a catheter adjacent to a pacemaker node of the heart
US5172699A (en) 1990-10-19 1992-12-22 Angelase, Inc. Process of identification of a ventricular tachycardia (VT) active site and an ablation catheter system
US5366487A (en) 1992-03-09 1994-11-22 Angeion Corporation Fibrillation and tachycardia detection
US5427112A (en) 1992-12-18 1995-06-27 Siemens Elema Ab Device for analyzing the function of a heart
US5433198A (en) 1993-03-11 1995-07-18 Desai; Jawahar M. Apparatus and method for cardiac ablation
US5439483A (en) 1993-10-21 1995-08-08 Ventritex, Inc. Method of quantifying cardiac fibrillation using wavelet transform
US5450846A (en) * 1993-01-08 1995-09-19 Goldreyer; Bruce N. Method for spatially specific electrophysiological sensing for mapping, pacing and ablating human myocardium and a catheter for the same
US5480422A (en) * 1993-07-20 1996-01-02 Biosense, Inc. Apparatus for treating cardiac arrhythmias
US5582173A (en) 1995-09-18 1996-12-10 Siemens Medical Systems, Inc. System and method for 3-D medical imaging using 2-D scan data
US5657755A (en) 1993-03-11 1997-08-19 Desai; Jawahar M. Apparatus and method for cardiac ablation
US5662108A (en) 1992-09-23 1997-09-02 Endocardial Solutions, Inc. Electrophysiology mapping system
US5718241A (en) * 1995-06-07 1998-02-17 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias with no discrete target
US5817134A (en) 1997-02-25 1998-10-06 Greenhut; Saul E. Apparatus and method for detecting atrial fibrillation by morphological analysis
US5836889A (en) * 1996-03-04 1998-11-17 Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin Method and apparatus for storing signals in an implantable medical device
US5848972A (en) 1995-09-15 1998-12-15 Children's Medical Center Corporation Method for endocardial activation mapping using a multi-electrode catheter
US5868680A (en) 1997-09-23 1999-02-09 The Regents Of The University Of California Quantitative characterization of fibrillatory spatiotemporal organization
US5954665A (en) * 1995-06-07 1999-09-21 Biosense, Inc. Cardiac ablation catheter using correlation measure
US6052618A (en) 1997-07-11 2000-04-18 Siemens-Elema Ab Device for mapping electrical activity in the heart
US6066094A (en) * 1993-07-20 2000-05-23 Biosense, Inc. Cardiac electromechanics
US6112117A (en) 1997-05-06 2000-08-29 Cardiac Pacemakers, Inc. Method and apparatus for treating cardiac arrhythmia using electrogram features
US6236883B1 (en) 1999-02-03 2001-05-22 The Trustees Of Columbia University In The City Of New York Methods and systems for localizing reentrant circuits from electrogram features
US6301496B1 (en) 1998-07-24 2001-10-09 Biosense, Inc. Vector mapping of three-dimensionally reconstructed intrabody organs and method of display
US20020010392A1 (en) 1993-03-11 2002-01-24 Desai Jawahar M. Apparatus and method for cardiac ablation
US6360121B1 (en) 1999-07-27 2002-03-19 Hiroshi Kasanaki Intracardiac potential analyzing apparatus and method
US6584345B2 (en) 2001-03-13 2003-06-24 Biosense, Inc. Apparatus and method for measuring a plurality of electrical signals from the body of a patient
US20030236466A1 (en) 2002-06-21 2003-12-25 Tarjan Peter P. Single or multi-mode cardiac activity data collection, processing and display obtained in a non-invasive manner
US6847839B2 (en) 2001-07-30 2005-01-25 The Trustees Of Columbia University In The City Of New York System and method for determining reentrant ventricular tachycardia isthmus location and shape for catheter ablation
US6856830B2 (en) 2001-07-19 2005-02-15 Bin He Method and apparatus of three dimension electrocardiographic imaging
US6892091B1 (en) 2000-02-18 2005-05-10 Biosense, Inc. Catheter, method and apparatus for generating an electrical map of a chamber of the heart
US6920350B2 (en) 2001-08-06 2005-07-19 Ge Medical Systems-Information Technologies, Inc. Method of and apparatus for displaying and analyzing a physiological signal
US6941166B2 (en) 2000-11-10 2005-09-06 C.R. Bard, Inc. Software controlled electrophysiology data management
US20050203502A1 (en) 2005-04-22 2005-09-15 Boveja Birinder R. Method and system for monitoring atrial fibrillation ablations with an ablation interface device
US6959212B2 (en) 1999-02-12 2005-10-25 Cardiac Pacemakers, Inc. System and method for arrhythmia discrimination
US6975900B2 (en) 1997-07-31 2005-12-13 Case Western Reserve University Systems and methods for determining a surface geometry
US7016719B2 (en) 1997-07-31 2006-03-21 Case Western Reserve University System and methods for noninvasive electrocardiographic imaging (ECGI) using generalized minimum residual (GMRes)
WO2006052838A2 (en) 2004-11-04 2006-05-18 Washington University Of St. Louis Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US7117030B2 (en) 2004-12-02 2006-10-03 The Research Foundation Of State University Of New York Method and algorithm for spatially identifying sources of cardiac fibrillation
US7123954B2 (en) * 2002-09-19 2006-10-17 Sanjiv Mathur Narayan Method for classifying and localizing heart arrhythmias
US20070055167A1 (en) 2005-09-02 2007-03-08 Bullinga John R System and method for analysis of cardiac arrhythmia using timing and variability of relationships between elctrogram features
US7206630B1 (en) 2004-06-29 2007-04-17 Cleveland Medical Devices, Inc Electrode patch and wireless physiological measurement system and method
WO2007078421A2 (en) 2005-12-20 2007-07-12 Cardiac Pacemakers, Inc. Hemodynamically controlled anti-tachyarrhythmia pacing system
US7263397B2 (en) 1998-06-30 2007-08-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for catheter navigation and location and mapping in the heart
US20070208260A1 (en) 2005-09-15 2007-09-06 Afonso Valtino X System and method for mapping complex fractionated electrogram information
WO2007106829A2 (en) 2006-03-14 2007-09-20 Cardionet, Inc. Automated analysis of a cardiac signal based on dynamical characteristics of the cardiac signal
US20070239051A1 (en) 2006-03-29 2007-10-11 Ghanem Raja N Method and apparatus for detecting arrhythmias in a medical device
US7283865B2 (en) 2002-02-28 2007-10-16 St. Jude Medical Ab Device and method for determining a cardiac condition using a complex signal formed from a detected cardiac signal
US7289845B2 (en) 2000-10-31 2007-10-30 Cardiac Pacemakers, Inc. Curvature based method for selecting features from an electrophysiologic signal for purpose of complex identification and classification
US20070299351A1 (en) 2006-06-13 2007-12-27 Doron Harlev Non-contact cardiac mapping, including resolution map
US7328063B2 (en) 2004-11-30 2008-02-05 Cardiac Pacemakers, Inc. Method and apparatus for arrhythmia classification using atrial signal mapping
US20080269624A1 (en) 2007-04-27 2008-10-30 Xin Zhang Morphology based arrhythmia detection
US20090069704A1 (en) 2007-05-08 2009-03-12 C.R. Bard, Inc. Rapid 3d mapping using multielectrode position data
US7505810B2 (en) 2006-06-13 2009-03-17 Rhythmia Medical, Inc. Non-contact cardiac mapping, including preprocessing
US7515954B2 (en) 2006-06-13 2009-04-07 Rhythmia Medical, Inc. Non-contact cardiac mapping, including moving catheter and multi-beat integration
US20090099468A1 (en) 2004-12-21 2009-04-16 Aravinda Thiagalingam Automated Processing of Electrophysiological Data
US20090112199A1 (en) 2007-10-25 2009-04-30 Siemens Medical Solutions Usa,Inc. Ep signal mapping-based optical ablation for patient monitoring and medical applications
CN101461711A (en) 2009-01-12 2009-06-24 复旦大学 Shockable rhythm recognition algorithm based on standard deviation of standard slope absolute value
US20090299424A1 (en) 2008-05-13 2009-12-03 Narayan Sanjiv M Methods and systems for treating heart instability
US7657307B2 (en) 2005-10-31 2010-02-02 Medtronic, Inc. Method of and apparatus for classifying arrhythmias using scatter plot analysis
US20100026543A1 (en) 2008-08-01 2010-02-04 Ali Corporation Analog to digital converter
US20100094274A1 (en) * 2008-10-09 2010-04-15 Sanjiv Narayan Methods, system and appartus for the detection, diagnosis and treatment of biological rhythm disorders
US20100204592A1 (en) * 2009-02-11 2010-08-12 Edwards Lifesciences Corporation Detection of Parameters in Cardiac Output Related Waveforms
US7801594B1 (en) 2007-10-22 2010-09-21 Pacesetter, Inc. Morphology discrimination based on inflection point-related information
US20110077540A1 (en) 2006-10-19 2011-03-31 Andres Belalcazar Method and apparatus for detecting fibrillation using cardiac local impedance
EP1808124B1 (en) 2006-01-12 2011-04-13 Biosense Webster, Inc. Mapping of complex fractionated atrial electrogram
US20110087121A1 (en) * 2009-10-13 2011-04-14 Siemens Medical Solutions Usa, Inc. System for Continuous cardiac pathology detection and characterization
US20110112425A1 (en) * 2008-05-09 2011-05-12 Koninklijke Philips Electronics N.V. Contactless respiration monitoring of a patient
US20110251505A1 (en) * 2010-04-08 2011-10-13 Topera Medical, Inc. Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders
US20110282227A1 (en) 2010-05-12 2011-11-17 Siemens Medical Solutions Usa, Inc. System for Cardiac Medical Condition Detection
US8165666B1 (en) 2011-05-02 2012-04-24 Topera, Inc. System and method for reconstructing cardiac activation information

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4630204A (en) 1984-02-21 1986-12-16 Mortara Instrument Inc. High resolution ECG waveform processor
DE3686951D1 (en) 1986-11-20 1992-11-12 Davies David Wyn An apparatus for detecting the rejection after heart transplantation.
CN1009330B (en) 1987-03-30 1990-08-29 创建基立有限公司 Apparatus and method for detecting and processing bioelectric signals
US5687737A (en) 1992-10-09 1997-11-18 Washington University Computerized three-dimensional cardiac mapping with interactive visual displays
US20070161915A1 (en) 1993-03-11 2007-07-12 Desai Jawahar M Apparatus And Method For Cardiac Ablation
EP0766527A1 (en) 1995-04-20 1997-04-09 Jawahar M. Desai Apparatus for cardiac ablation
EP0673225A4 (en) 1993-03-16 1996-01-24 Ep Technologies Cardiac mapping and ablation systems.
DE69738547T2 (en) 1996-01-08 2009-03-26 Biosense Webster, Inc., Diamond Bar Kartierender catheter
WO1995020344A1 (en) 1994-01-28 1995-08-03 Ep Technologies, Inc. System for examining cardiac tissue electrical characteristics
US5487391A (en) 1994-01-28 1996-01-30 Ep Technologies, Inc. Systems and methods for deriving and displaying the propagation velocities of electrical events in the heart
US5458621A (en) 1994-03-15 1995-10-17 Incontrol, Inc. Automatic gain control and method for enabling detection of low and high amplitude depolarization activation waves of the heart and atrial defibrillator utilizing the same
JP3681126B2 (en) 1995-02-17 2005-08-10 ボストン サイエンティフィック リミテッド System for the time-series measurement of biological events
WO1996025096A1 (en) 1995-02-17 1996-08-22 Ep Technologies, Inc. Acquisition of endocardially or epicardially paced electrocardiograms
US5711305A (en) 1995-02-17 1998-01-27 Ep Technologies, Inc. Systems and methods for acquiring endocardially or epicardially paced electrocardiograms
EP0830091B1 (en) 1995-04-20 2003-10-29 Jawahar M. Desai Apparatus for cardiac mapping and ablation
US5645070A (en) 1995-09-25 1997-07-08 Ventritex, Inc. Method and apparatus for determining the origins of cardiac arrhythmias morphology dynamics
WO1997017893A1 (en) 1995-11-13 1997-05-22 Heart Rhythm Technologies, Inc. System and method for analyzing electrogram waveforms
CA2190925A1 (en) 1995-11-22 1997-05-23 Lambert Muhlenberg System and method for compressing digitized signals in implantable and battery powered devices
US6106460A (en) 1998-03-26 2000-08-22 Scimed Life Systems, Inc. Interface for controlling the display of images of diagnostic or therapeutic instruments in interior body regions and related data
US6208888B1 (en) 1999-02-03 2001-03-27 Cardiac Pacemakers, Inc. Voltage sensing system with input impedance balancing for electrocardiogram (ECG) sensing applications
US6438409B1 (en) 1999-03-25 2002-08-20 Medtronic, Inc. Methods of characterizing ventricular operations and applications thereof
US6324421B1 (en) 1999-03-29 2001-11-27 Medtronic, Inc. Axis shift analysis of electrocardiogram signal parameters especially applicable for multivector analysis by implantable medical devices, and use of same
US6115628A (en) 1999-03-29 2000-09-05 Medtronic, Inc. Method and apparatus for filtering electrocardiogram (ECG) signals to remove bad cycle information and for use of physiologic signals determined from said filtered ECG signals
DE60032751D1 (en) 1999-04-05 2007-02-15 Univ California Endomyocardial monophasic action potentials for early evidence of myocardium pathology
US6449503B1 (en) 1999-07-14 2002-09-10 Cardiac Pacemakers, Inc. Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm
US6725085B2 (en) 2000-09-22 2004-04-20 Armin Schwartzman Method and apparatus for characterizing cardiac tissue from local electrograms
US7369890B2 (en) 2000-11-02 2008-05-06 Cardiac Pacemakers, Inc. Technique for discriminating between coordinated and uncoordinated cardiac rhythms
US6510339B2 (en) 2000-12-06 2003-01-21 Cardiac Pacemakers, Inc. ECG auto-gain control
US6766190B2 (en) 2001-10-31 2004-07-20 Medtronic, Inc. Method and apparatus for developing a vectorcardiograph in an implantable medical device
US6950696B2 (en) 2001-11-27 2005-09-27 St. Jude Medical Ab Method and circuit for detecting cardiac rhythm abnormalities by analyzing time differences between unipolar signals from a lead with a multi-electrode tip
US6882882B2 (en) * 2002-04-22 2005-04-19 Medtronic, Inc. Atrioventricular delay adjustment
US6950702B2 (en) 2002-07-15 2005-09-27 Cardiac Pacemakers, Inc. Use of curvature based features for beat detection
US7215993B2 (en) 2002-08-06 2007-05-08 Cardiac Pacemakers, Inc. Cardiac rhythm management systems and methods for detecting or validating cardiac beats in the presence of noise
US7031764B2 (en) 2002-11-08 2006-04-18 Cardiac Pacemakers, Inc. Cardiac rhythm management systems and methods using multiple morphology templates for discriminating between rhythms
US7076288B2 (en) 2003-01-29 2006-07-11 Vicor Technologies, Inc. Method and system for detecting and/or predicting biological anomalies
US6985768B2 (en) 2003-02-28 2006-01-10 Medtronic, Inc. Physiological event detection
US7477932B2 (en) 2003-05-28 2009-01-13 Cardiac Pacemakers, Inc. Cardiac waveform template creation, maintenance and use
US7233824B2 (en) * 2003-10-07 2007-06-19 Medtronic, Inc. Secure and efficacious therapy delivery for an extra-systolic stimulation pacing engine
WO2005112749A1 (en) 2004-05-12 2005-12-01 Zoll Medical Corporation Ecg rhythm advisory method
US20050288599A1 (en) 2004-05-17 2005-12-29 C.R. Bard, Inc. High density atrial fibrillation cycle length (AFCL) detection and mapping system
US7797036B2 (en) 2004-11-30 2010-09-14 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring for ischemia detection
US7567835B2 (en) 2005-04-18 2009-07-28 Medtronic, Inc. Method and apparatus for identifying oversensing using far-field intracardiac electrograms and marker channels
EP1897028A2 (en) 2005-06-09 2008-03-12 Philips Electronics N.V. Method and apparatus for distinguishing between clinically significant changes and artifacts in patient physiological information
WO2006131851A1 (en) 2005-06-09 2006-12-14 Koninklijke Philips Electronics, N.V. Morphograms in different time scales for robust trend analysis in intensive/critical care unit patients
US7529578B2 (en) 2005-07-12 2009-05-05 Cardiac Pacemakers, Inc. Multi channel approach to capture verification
EP1937357A4 (en) 2005-09-06 2012-02-29 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to a heart
US7974691B2 (en) 2005-09-21 2011-07-05 Cardiac Pacemakers, Inc. Method and apparatus for controlling cardiac resynchronization therapy using cardiac impedance
US7751882B1 (en) 2005-12-21 2010-07-06 Pacesetter, Inc. Method and system for determining lead position for optimized cardiac resynchronization therapy hemodynamics
US7962202B2 (en) 2006-03-31 2011-06-14 Medtronic, Inc. Method and apparatus for verifying a determined cardiac event in a medical device based on detected variation in hemodynamic status
WO2007146864A3 (en) 2006-06-13 2008-12-04 Rhythmia Medical Inc Non-contact cardiac mapping, including moving catheter and multi-beat integration
GB0618522D0 (en) 2006-09-20 2006-11-01 Imp Innovations Ltd Atrial fibrillation analysis
US7738948B2 (en) 2006-10-31 2010-06-15 Medtronic, Inc. Form parameter forecaster for analyzing signals distorted by noise
US7751873B2 (en) * 2006-11-08 2010-07-06 Biotronik Crm Patent Ag Wavelet based feature extraction and dimension reduction for the classification of human cardiac electrogram depolarization waveforms
US7996055B2 (en) 2006-12-29 2011-08-09 St. Jude Medical, Atrial Fibrillation Division, Inc. Cardiac navigation system including electrode array for use therewith
US7907994B2 (en) 2007-01-11 2011-03-15 Biosense Webster, Inc. Automated pace-mapping for identification of cardiac arrhythmic conductive pathways and foci
US7890172B2 (en) 2007-01-18 2011-02-15 Cardiac Pacemakers, Inc. Pacing output configuration selection for cardiac resynchronization therapy patients
US8095206B2 (en) 2007-05-01 2012-01-10 Medtronic, Inc. Method and apparatus for detecting arrhythmias in a medical device
US8588885B2 (en) 2007-05-09 2013-11-19 St. Jude Medical, Atrial Fibrillation Division, Inc. Bendable catheter arms having varied flexibility
US8666483B2 (en) 2007-10-24 2014-03-04 Siemens Medical Solutions Usa, Inc. System for cardiac medical condition detection and characterization
US8396541B2 (en) 2007-10-24 2013-03-12 Siemens Medical Solutions Usa, Inc. Signal analysis of cardiac and other patient medical signals
US8050751B2 (en) 2008-07-31 2011-11-01 Medtronic, Inc. Periodic beat detection to detect artifacts in a cardiac electrogram
US8265741B2 (en) 2009-02-23 2012-09-11 Biotronik Crm Patent Ag Technique for determining signal quality in a physiologic sensing system using high frequency sampling
US20100239627A1 (en) 2009-03-20 2010-09-23 Wilson Kurt Whitekettle Quarternary ammonium salts delivery systems
US8301233B2 (en) * 2009-03-31 2012-10-30 Medtronic, Inc. Detecting a condition of a patient using a probability-correlation based model
US8460196B2 (en) 2009-05-29 2013-06-11 Atlantis Limited Partnership Method and apparatus for monitoring brain activity
EP2353644B1 (en) 2010-02-09 2012-07-04 BIOTRONIK SE & Co. KG Cardioverter/defibrillator and signal processing device for classifying intracardiac signals
JP5632539B2 (en) 2010-09-17 2014-11-26 カーディオインサイト テクノロジーズ インコーポレイテッド Systems and methods for computing the excitation propagation diagram
US8340766B2 (en) 2010-10-07 2012-12-25 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and system for identifying cardiac arrhythmia driver sites
US9002442B2 (en) 2011-01-13 2015-04-07 Rhythmia Medical, Inc. Beat alignment and selection for cardiac mapping
US8433398B2 (en) 2011-03-10 2013-04-30 Siemens Medical Solutions Usa, Inc. Signal analysis system for heart condition determination
WO2012151301A1 (en) 2011-05-02 2012-11-08 Topera, Inc. System and method for targeting heart rhythm disorders using shaped ablation
US9107600B2 (en) 2011-05-02 2015-08-18 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9050006B2 (en) 2011-05-02 2015-06-09 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9392948B2 (en) 2011-12-09 2016-07-19 The Regents Of The University Of California System and method of identifying sources for biological rhythms
CN104717918B (en) 2012-06-20 2017-07-04 波士顿科学医学有限公司 During electrophysiological mapping enhanced signal vector analysis to inhibit activated globally
US9295399B2 (en) 2012-06-20 2016-03-29 Intermountain Invention Management, Llc Atrial fibrillation treatment systems and methods
US9031642B2 (en) 2013-02-21 2015-05-12 Medtronic, Inc. Methods for simultaneous cardiac substrate mapping using spatial correlation maps between neighboring unipolar electrograms
US8715199B1 (en) 2013-03-15 2014-05-06 Topera, Inc. System and method to define a rotational source associated with a biological rhythm disorder
US9332915B2 (en) 2013-03-15 2016-05-10 The Regents Of The University Of California System and method to identify sources associated with biological rhythm disorders
JP2017521117A (en) * 2014-06-20 2017-08-03 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for the mapping of the heart tissue

Patent Citations (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5121750A (en) 1990-03-02 1992-06-16 Katims Jefferson J Apparatus for locating a catheter adjacent to a pacemaker node of the heart
US5172699A (en) 1990-10-19 1992-12-22 Angelase, Inc. Process of identification of a ventricular tachycardia (VT) active site and an ablation catheter system
US5366487A (en) 1992-03-09 1994-11-22 Angeion Corporation Fibrillation and tachycardia detection
US20060084970A1 (en) 1992-09-23 2006-04-20 Endocardial Solutions, Inc. Mapping physiological data in a heart chamber
US5662108A (en) 1992-09-23 1997-09-02 Endocardial Solutions, Inc. Electrophysiology mapping system
US7289843B2 (en) 1992-09-23 2007-10-30 St. Jude Medical, Atrial Fibrillation Division, Inc. Software for mapping potential distribution of a heart chamber
US6978168B2 (en) 1992-09-23 2005-12-20 Endocardial Solutions, Inc. Software for mapping potential distribution of a heart chamber
US5427112A (en) 1992-12-18 1995-06-27 Siemens Elema Ab Device for analyzing the function of a heart
US5450846A (en) * 1993-01-08 1995-09-19 Goldreyer; Bruce N. Method for spatially specific electrophysiological sensing for mapping, pacing and ablating human myocardium and a catheter for the same
US6522905B2 (en) 1993-03-11 2003-02-18 Jawahar M. Desai Apparatus and method for cardiac ablation
US5657755A (en) 1993-03-11 1997-08-19 Desai; Jawahar M. Apparatus and method for cardiac ablation
US5433198A (en) 1993-03-11 1995-07-18 Desai; Jawahar M. Apparatus and method for cardiac ablation
US20020010392A1 (en) 1993-03-11 2002-01-24 Desai Jawahar M. Apparatus and method for cardiac ablation
US20050148892A1 (en) 1993-03-11 2005-07-07 Desai Jawahar M. Apparatus and method for cardiac ablation
US5840025A (en) 1993-07-20 1998-11-24 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias
US6066094A (en) * 1993-07-20 2000-05-23 Biosense, Inc. Cardiac electromechanics
US5480422A (en) * 1993-07-20 1996-01-02 Biosense, Inc. Apparatus for treating cardiac arrhythmias
US5439483A (en) 1993-10-21 1995-08-08 Ventritex, Inc. Method of quantifying cardiac fibrillation using wavelet transform
US5718241A (en) * 1995-06-07 1998-02-17 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias with no discrete target
US5954665A (en) * 1995-06-07 1999-09-21 Biosense, Inc. Cardiac ablation catheter using correlation measure
US5848972A (en) 1995-09-15 1998-12-15 Children's Medical Center Corporation Method for endocardial activation mapping using a multi-electrode catheter
US5582173A (en) 1995-09-18 1996-12-10 Siemens Medical Systems, Inc. System and method for 3-D medical imaging using 2-D scan data
US5836889A (en) * 1996-03-04 1998-11-17 Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin Method and apparatus for storing signals in an implantable medical device
US5817134A (en) 1997-02-25 1998-10-06 Greenhut; Saul E. Apparatus and method for detecting atrial fibrillation by morphological analysis
US6112117A (en) 1997-05-06 2000-08-29 Cardiac Pacemakers, Inc. Method and apparatus for treating cardiac arrhythmia using electrogram features
US6539256B1 (en) 1997-05-06 2003-03-25 Cardiac Pacemakers, Inc. Method and apparatus for treating cardiac arrhythmia using electrogram features
US6251125B1 (en) 1997-05-06 2001-06-26 Cardiac Pacemakers, Inc. Method and apparatus for treating ventricular fibrillation using electrogram features
US6052618A (en) 1997-07-11 2000-04-18 Siemens-Elema Ab Device for mapping electrical activity in the heart
US6975900B2 (en) 1997-07-31 2005-12-13 Case Western Reserve University Systems and methods for determining a surface geometry
US7016719B2 (en) 1997-07-31 2006-03-21 Case Western Reserve University System and methods for noninvasive electrocardiographic imaging (ECGI) using generalized minimum residual (GMRes)
US5868680A (en) 1997-09-23 1999-02-09 The Regents Of The University Of California Quantitative characterization of fibrillatory spatiotemporal organization
US7263397B2 (en) 1998-06-30 2007-08-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for catheter navigation and location and mapping in the heart
US6301496B1 (en) 1998-07-24 2001-10-09 Biosense, Inc. Vector mapping of three-dimensionally reconstructed intrabody organs and method of display
US6236883B1 (en) 1999-02-03 2001-05-22 The Trustees Of Columbia University In The City Of New York Methods and systems for localizing reentrant circuits from electrogram features
US6959212B2 (en) 1999-02-12 2005-10-25 Cardiac Pacemakers, Inc. System and method for arrhythmia discrimination
US6360121B1 (en) 1999-07-27 2002-03-19 Hiroshi Kasanaki Intracardiac potential analyzing apparatus and method
US6892091B1 (en) 2000-02-18 2005-05-10 Biosense, Inc. Catheter, method and apparatus for generating an electrical map of a chamber of the heart
US7289845B2 (en) 2000-10-31 2007-10-30 Cardiac Pacemakers, Inc. Curvature based method for selecting features from an electrophysiologic signal for purpose of complex identification and classification
EP2269691A2 (en) 2000-10-31 2011-01-05 Cardiac Pacemakers, Inc. Curvature-based feature selection for electrophysiologic signals
US6941166B2 (en) 2000-11-10 2005-09-06 C.R. Bard, Inc. Software controlled electrophysiology data management
US6584345B2 (en) 2001-03-13 2003-06-24 Biosense, Inc. Apparatus and method for measuring a plurality of electrical signals from the body of a patient
US6856830B2 (en) 2001-07-19 2005-02-15 Bin He Method and apparatus of three dimension electrocardiographic imaging
US6847839B2 (en) 2001-07-30 2005-01-25 The Trustees Of Columbia University In The City Of New York System and method for determining reentrant ventricular tachycardia isthmus location and shape for catheter ablation
US7245962B2 (en) 2001-07-30 2007-07-17 The Trustees Of Columbia University In The City Of New York System and method for determining reentrant ventricular tachycardia isthmus location and shape for catheter ablation
US6920350B2 (en) 2001-08-06 2005-07-19 Ge Medical Systems-Information Technologies, Inc. Method of and apparatus for displaying and analyzing a physiological signal
US7283865B2 (en) 2002-02-28 2007-10-16 St. Jude Medical Ab Device and method for determining a cardiac condition using a complex signal formed from a detected cardiac signal
US7043292B2 (en) 2002-06-21 2006-05-09 Tarjan Peter P Single or multi-mode cardiac activity data collection, processing and display obtained in a non-invasive manner
US20030236466A1 (en) 2002-06-21 2003-12-25 Tarjan Peter P. Single or multi-mode cardiac activity data collection, processing and display obtained in a non-invasive manner
US7123954B2 (en) * 2002-09-19 2006-10-17 Sanjiv Mathur Narayan Method for classifying and localizing heart arrhythmias
US7206630B1 (en) 2004-06-29 2007-04-17 Cleveland Medical Devices, Inc Electrode patch and wireless physiological measurement system and method
US20060161206A1 (en) 2004-11-04 2006-07-20 Efimov Igor R Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
WO2006052838A2 (en) 2004-11-04 2006-05-18 Washington University Of St. Louis Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries
US20080114258A1 (en) 2004-11-30 2008-05-15 Cardiac Pacemakers, Inc. Method and apparatus for arrhythmia classification using atrial signal mapping
US7328063B2 (en) 2004-11-30 2008-02-05 Cardiac Pacemakers, Inc. Method and apparatus for arrhythmia classification using atrial signal mapping
US7117030B2 (en) 2004-12-02 2006-10-03 The Research Foundation Of State University Of New York Method and algorithm for spatially identifying sources of cardiac fibrillation
US20090099468A1 (en) 2004-12-21 2009-04-16 Aravinda Thiagalingam Automated Processing of Electrophysiological Data
US20050203502A1 (en) 2005-04-22 2005-09-15 Boveja Birinder R. Method and system for monitoring atrial fibrillation ablations with an ablation interface device
US20070055167A1 (en) 2005-09-02 2007-03-08 Bullinga John R System and method for analysis of cardiac arrhythmia using timing and variability of relationships between elctrogram features
US20070208260A1 (en) 2005-09-15 2007-09-06 Afonso Valtino X System and method for mapping complex fractionated electrogram information
US7657307B2 (en) 2005-10-31 2010-02-02 Medtronic, Inc. Method of and apparatus for classifying arrhythmias using scatter plot analysis
WO2007078421A2 (en) 2005-12-20 2007-07-12 Cardiac Pacemakers, Inc. Hemodynamically controlled anti-tachyarrhythmia pacing system
EP1808124B1 (en) 2006-01-12 2011-04-13 Biosense Webster, Inc. Mapping of complex fractionated atrial electrogram
WO2007106829A2 (en) 2006-03-14 2007-09-20 Cardionet, Inc. Automated analysis of a cardiac signal based on dynamical characteristics of the cardiac signal
US7729753B2 (en) 2006-03-14 2010-06-01 Cardionet, Inc. Automated analysis of a cardiac signal based on dynamical characteristics of the cardiac signal
US7742812B2 (en) 2006-03-29 2010-06-22 Medtronic, Inc. Method and apparatus for detecting arrhythmias in a medical device
US20070239051A1 (en) 2006-03-29 2007-10-11 Ghanem Raja N Method and apparatus for detecting arrhythmias in a medical device
US7761150B2 (en) 2006-03-29 2010-07-20 Medtronic, Inc. Method and apparatus for detecting arrhythmias in a medical device
US7761142B2 (en) 2006-03-29 2010-07-20 Medtronic, Inc. Method and apparatus for detecting arrhythmias in a medical device
US7734336B2 (en) 2006-03-29 2010-06-08 Medtronic, Inc. Method and apparatus for detecting arrhythmias in a medical device
US20070299351A1 (en) 2006-06-13 2007-12-27 Doron Harlev Non-contact cardiac mapping, including resolution map
US20090177071A1 (en) 2006-06-13 2009-07-09 Rhythmia Medical, Inc. Non-Contact Cardiac Mapping, Including Preprocessing
US7505810B2 (en) 2006-06-13 2009-03-17 Rhythmia Medical, Inc. Non-contact cardiac mapping, including preprocessing
US20090177072A1 (en) 2006-06-13 2009-07-09 Rhythmia Medical, Inc. Non-Contact Cardiac Mapping, Including Moving Catheter and Multi-Beat Integration
US7515954B2 (en) 2006-06-13 2009-04-07 Rhythmia Medical, Inc. Non-contact cardiac mapping, including moving catheter and multi-beat integration
US20110077540A1 (en) 2006-10-19 2011-03-31 Andres Belalcazar Method and apparatus for detecting fibrillation using cardiac local impedance
US7930020B2 (en) 2007-04-27 2011-04-19 Medtronic, Inc. Morphology based arrhythmia detection
US20080269624A1 (en) 2007-04-27 2008-10-30 Xin Zhang Morphology based arrhythmia detection
US20090069704A1 (en) 2007-05-08 2009-03-12 C.R. Bard, Inc. Rapid 3d mapping using multielectrode position data
US20100324435A1 (en) 2007-10-22 2010-12-23 Paul Higham Morphology discrimination based on inflection point-related information
US7801594B1 (en) 2007-10-22 2010-09-21 Pacesetter, Inc. Morphology discrimination based on inflection point-related information
US20090112199A1 (en) 2007-10-25 2009-04-30 Siemens Medical Solutions Usa,Inc. Ep signal mapping-based optical ablation for patient monitoring and medical applications
US20110112425A1 (en) * 2008-05-09 2011-05-12 Koninklijke Philips Electronics N.V. Contactless respiration monitoring of a patient
US20090299424A1 (en) 2008-05-13 2009-12-03 Narayan Sanjiv M Methods and systems for treating heart instability
US20100026543A1 (en) 2008-08-01 2010-02-04 Ali Corporation Analog to digital converter
US20100094274A1 (en) * 2008-10-09 2010-04-15 Sanjiv Narayan Methods, system and appartus for the detection, diagnosis and treatment of biological rhythm disorders
CN101461711A (en) 2009-01-12 2009-06-24 复旦大学 Shockable rhythm recognition algorithm based on standard deviation of standard slope absolute value
US20100204592A1 (en) * 2009-02-11 2010-08-12 Edwards Lifesciences Corporation Detection of Parameters in Cardiac Output Related Waveforms
US20110087121A1 (en) * 2009-10-13 2011-04-14 Siemens Medical Solutions Usa, Inc. System for Continuous cardiac pathology detection and characterization
US20110251505A1 (en) * 2010-04-08 2011-10-13 Topera Medical, Inc. Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders
US20110282227A1 (en) 2010-05-12 2011-11-17 Siemens Medical Solutions Usa, Inc. System for Cardiac Medical Condition Detection
US8165666B1 (en) 2011-05-02 2012-04-24 Topera, Inc. System and method for reconstructing cardiac activation information

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
Ciaccio, Edward J. et al., "Development of Gradient Descent Adaptive Algorithms to Remove Common Mode Artifact for Improvement of Cardiovascular Signal Quality", Annals of Biomedical Engineering, vol. 35, No. 7, Jul. 2007, pp. 1146-1155.
Ciaccio, Edward J. et al., "Development of Gradient Descent Adaptive Algorithms to Remove Common Mode Artifact for Improvement of Cariovascular Signal Quality", Annals of Biomedical Engineering, vol. 35, No. 7, Jul. 2007, pp. 1146-1155.
English-language translation of Chinese patent publication No. CN 101461711A, published Jun. 24, 2009.
Houben, R.P.M., et al, "Automatic mapping of human atrial fibrillation by template matching", Heart Rhythm, vol. 3, No. 10, Oct. 1, 2006, pp. 1221-1228.
International Search Report and Written Opinion issued in PCT/US12/29935 dated Nov. 8, 2012, 9 pages.
Nademanee, Koonlawee, et al., "A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate", J. Amer.Coll.Cardiol., vol. 43, No. 11, Jun. 2, 2004, pp. 2044-2053.
Narayan, S.M., et al., "Dynamics factors preceding the initiation of atrial fibrillation in humans", Heart Rhythm, vol. 5, No. 6, Jun. 1, 2008, pp. S22-S25.
Sornborger, Andrew, et al., "Extraction of Periodic Multivariate Signals: Mapping of Voltage-Dependent Dye Fluorescence in the Mouse Heart", IEEE Transactions on Medical Imaging, vol. 22, No. 12, Dec. 2003, pp. 1537-1549.
Sun, Yan, et al., "Characteristic wave detection in ECG signal using morphological transform", BMC Cardiovascular Disorders, vol. 5, No. 28, 2005.
Tai, Dean C.S., et al., "Correction of motion artifact in transmembrane voltage-sensitive fluorescent dye emission in hearts", Am. J. Physiol. Heart Circ. Physiol., vol. 287, 2004, pp. H985-H993.
U.S. Appl. No. 13/081,411, filed Apr. 6, 2011.

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393425B2 (en) 2008-05-13 2016-07-19 The Regents Of The University Of California Methods and systems for detecting and treating heart instability
US9375156B2 (en) 2008-10-09 2016-06-28 The Regents Of The University Of California System for analysis of complex rhythm disorders
US20160278657A1 (en) * 2008-10-09 2016-09-29 The Regents Of The University Of California System for analysis of complex rhythm disorders
US9439573B2 (en) 2008-10-09 2016-09-13 The Regents Of The University Of California Method for analysis of complex rhythm disorders
US9380950B2 (en) 2008-10-09 2016-07-05 The Regents Of The University Of California Methods for detecting biological rhythm disorders
US9955879B2 (en) * 2008-10-09 2018-05-01 The Regents Of The University Of California System for analysis of complex rhythm disorders
US9241667B2 (en) 2010-04-08 2016-01-26 The Regents Of The University Of California System and method for reconstructing cardiac signals associated with a complex rhythm disorder
US9717436B2 (en) 2010-04-08 2017-08-01 The Regents Of The University Of California Method and system for detection of biological rhythm disorders
US9549684B2 (en) 2010-04-08 2017-01-24 The Regents Of The University Of California System and method for reconstructing cardiac signals associated with a complex rhythm disorder
US9089269B2 (en) 2010-04-08 2015-07-28 The Regents Of The University Of California System and method for reconstructing cardiac signals associated with a complex rhythm disorder
US9050006B2 (en) * 2011-05-02 2015-06-09 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9220427B2 (en) 2011-05-02 2015-12-29 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9107600B2 (en) * 2011-05-02 2015-08-18 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9282910B2 (en) 2011-05-02 2016-03-15 The Regents Of The University Of California System and method for targeting heart rhythm disorders using shaped ablation
US9913615B2 (en) 2011-05-02 2018-03-13 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9055877B2 (en) * 2011-05-02 2015-06-16 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US20140371615A1 (en) * 2011-05-02 2014-12-18 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9055878B2 (en) * 2011-05-02 2015-06-16 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US20140371614A1 (en) * 2011-05-02 2014-12-18 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9398883B2 (en) * 2011-05-02 2016-07-26 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9668666B2 (en) 2011-05-02 2017-06-06 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US20140073981A1 (en) * 2011-05-02 2014-03-13 Topera, Inc. System and method for reconstructing cardiac activation information
US20140066787A1 (en) * 2011-05-02 2014-03-06 Topera, Inc. System and method for reconstructing cardiac activation information
US9468387B2 (en) 2011-05-02 2016-10-18 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9655535B2 (en) 2011-05-02 2017-05-23 The Regents Of The University Of California System and method for targeting heart rhythm disorders using shaped ablation
US9055876B2 (en) * 2011-05-02 2015-06-16 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US20130226016A1 (en) * 2011-05-02 2013-08-29 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US20160324434A1 (en) * 2011-12-09 2016-11-10 The Regents Of The University Of California System and method of identifying sources for biological rhythms
US9408536B2 (en) 2011-12-09 2016-08-09 The Regents Of The University Of California System and method of identifying sources for biological rhythms
US9392948B2 (en) 2011-12-09 2016-07-19 The Regents Of The University Of California System and method of identifying sources for biological rhythms
US9724009B2 (en) 2011-12-09 2017-08-08 The Regents Of The University Of California System and method of identifying sources for biological rhythms
US9332915B2 (en) 2013-03-15 2016-05-10 The Regents Of The University Of California System and method to identify sources associated with biological rhythm disorders

Also Published As

Publication number Publication date Type
US20140371615A1 (en) 2014-12-18 application
CN105997001A (en) 2016-10-12 application
WO2012151008A3 (en) 2013-01-03 application
CN106073711A (en) 2016-11-09 application
US8165666B1 (en) 2012-04-24 grant
CN105997002A (en) 2016-10-12 application
JP2014111176A (en) 2014-06-19 application
KR20140066125A (en) 2014-05-30 application
CN103813747A (en) 2014-05-21 application
US20140066787A1 (en) 2014-03-06 application
US9468387B2 (en) 2016-10-18 grant
US20150257710A1 (en) 2015-09-17 application
EP2533687A2 (en) 2012-12-19 application
US9055878B2 (en) 2015-06-16 grant
US20140073981A1 (en) 2014-03-13 application
JP5475926B2 (en) 2014-04-16 grant
WO2012151008A2 (en) 2012-11-08 application
JP2013533007A (en) 2013-08-22 application
US9055876B2 (en) 2015-06-16 grant
US20160360983A1 (en) 2016-12-15 application
US20120283579A1 (en) 2012-11-08 application
EP3001949A1 (en) 2016-04-06 application
CA2834944A1 (en) 2012-11-08 application
EP2533687A4 (en) 2013-10-09 application
US9055877B2 (en) 2015-06-16 grant
EP2533687B1 (en) 2016-07-27 grant
CN103813747B (en) 2016-08-17 grant
RU2013153107A (en) 2015-06-10 application

Similar Documents

Publication Publication Date Title
US7787951B1 (en) System and method for determining optimal stimulation sites based on ECG information
US6064906A (en) Method, system and apparatus for determining prognosis in atrial fibrillation
US7930018B2 (en) Cardiac mapping, including moving catheter and multi-beat integration
US7123954B2 (en) Method for classifying and localizing heart arrhythmias
US20070179392A1 (en) Rejection of noises caused by postural changes during acute myocardial infarction detection
US6556860B1 (en) System and method for developing a database of body surface ECG flutter wave data maps for classification of atrial flutter
US7505810B2 (en) Non-contact cardiac mapping, including preprocessing
US7729752B2 (en) Non-contact cardiac mapping, including resolution map
US20070073179A1 (en) System and Method for Three Dimensional Mapping of Electrophysiology Information
US20070208260A1 (en) System and method for mapping complex fractionated electrogram information
US20130190747A1 (en) Electrophysiology system and methods
US20100094274A1 (en) Methods, system and appartus for the detection, diagnosis and treatment of biological rhythm disorders
US20130006131A1 (en) System and Method for Targeting Heart Rhythm Disorders Using Shaped Ablation
US8010186B1 (en) System and related methods for identifying a fibrillation driver
US6799064B1 (en) Device for the mapping of cardiac arrhythmia foci
US8700140B2 (en) Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders
Abouezzeddine et al. Relevance of endocavitary structures in ablation procedures for ventricular tachycardia
US20130150740A1 (en) System and method of identifying sources for biological rhythms
US8165666B1 (en) System and method for reconstructing cardiac activation information
US20130345577A1 (en) Augmented signal vector analysis to suppress global activation during electrophysiology mapping
Mizuno et al. Contact force monitoring for cardiac mapping in patients with ventricular tachycardia
US20130226016A1 (en) System and method for reconstructing cardiac activation information
US20050182336A1 (en) Non-invasive localization and treatment of focal atrial fibrillation
US20130345537A1 (en) Far-field vs local activation discrimination on multi-electrode egms using vector analysis in multi-dimensional signal space
US20110172729A1 (en) Use of significant point methodology to prevent inappropriate therapy

Legal Events

Date Code Title Description
AS Assignment

Owner name: TOPERA, INC., ARIZONA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRIGGS, CAREY ROBERT;REEL/FRAME:027981/0664

Effective date: 20111006

AS Assignment

Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF CALIFORNIA SAN DIEGO;REEL/FRAME:029422/0288

Effective date: 20121205

AS Assignment

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CALIF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NARAYAN, SANJIV M.;REEL/FRAME:030886/0920

Effective date: 20130425

AS Assignment

Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF CALIFORNIA SAN DIEGO;REEL/FRAME:032247/0153

Effective date: 20140116

FPAY Fee payment

Year of fee payment: 4